MS
MCID: MLT020
MIFTS: 72

Multiple Sclerosis (MS)

Categories: Genetic diseases, Immune diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Multiple Sclerosis

MalaCards integrated aliases for Multiple Sclerosis:

Name: Multiple Sclerosis 56 12 74 52 25 53 73 36 54 6 42 43 15 37 17 71 32
Ms 56 52 25 73
Multiple Sclerosis, Disease Progression, Modifier of 56 13
Multiple Sclerosis Modifier of Disease Progression 29 6
Disseminated Sclerosis 56 25
Multiple Sclerosis, Susceptibility to, 1 56
Multiple Sclerosis, Susceptibility to 56
Multiple Sclerosis Susceptibility to 39
Generalized Multiple Sclerosis 12
Multiple Sclerosis Variant 58
Multiple Sclerosis 1 56
Insular Sclerosis 12

Characteristics:

OMIM:

56
Inheritance:
multifactorial

Miscellaneous:
onset 20-55 years of age
women affected more than men (3:2)
association with the hla-drb1*1501-dqb1*0602 haplotype has been repeatedly demonstrated in high-risk (northern european) populations.


HPO:

31
multiple sclerosis:
Inheritance multifactorial inheritance


Classifications:

Orphanet: 58  
Rare neurological diseases


External Ids:

Disease Ontology 12 DOID:2377
OMIM 56 126200
OMIM Phenotypic Series 56 PS126200
KEGG 36 H01490
ICD9CM 34 340
MeSH 43 D009103
NCIt 49 C3243
SNOMED-CT 67 24700007
ICD10 32 G35
Orphanet 58 ORPHA228145
MedGen 41 C1868685
UMLS 71 C0026769

Summaries for Multiple Sclerosis

Genetics Home Reference : 25 Multiple sclerosis is a condition characterized by areas of damage (lesions) on the brain and spinal cord. These lesions are associated with destruction of the covering that protects nerves and promotes the efficient transmission of nerve impulses (the myelin sheath) and damage to nerve cells. Multiple sclerosis is considered an autoimmune disorder; autoimmune disorders occur when the immune system malfunctions and attacks the body's own tissues and organs, in this case tissues of the nervous system. Multiple sclerosis usually begins in early adulthood, between ages 20 and 40. The symptoms vary widely, and affected individuals can experience one or more effects of nervous system damage. Multiple sclerosis often causes sensory disturbances in the limbs, including a prickling or tingling sensation (paresthesia), numbness, pain, and itching. Some people experience Lhermitte sign, which is an electrical shock-like sensation that runs down the back and into the limbs. This sensation usually occurs when the head is bent forward. Problems with muscle control are common in people with multiple sclerosis. Affected individuals may have tremors, muscle stiffness (spasticity), exaggerated reflexes (hyperreflexia), weakness or partial paralysis of the muscles of the limbs, difficulty walking, or poor bladder control. Multiple sclerosis is also associated with vision problems, such as blurred or double vision or partial or complete vision loss. Infections that cause fever can make the symptoms worse. There are several forms of multiple sclerosis: relapsing-remitting MS, secondary progressive MS, primary progressive MS, and progressive relapsing MS. The most common is the relapsing-remitting form, which affects approximately 80 percent of people with multiple sclerosis. Individuals with this form of the condition have periods during which they experience symptoms, called clinical attacks, followed by periods without any symptoms (remission). The triggers of clinical attacks and remissions are unknown. After about 10 years, relapsing-remitting MS usually develops into another form of the disorder called secondary progressive MS. In this form, there are no remissions, and symptoms of the condition continually worsen. Primary progressive MS is the next most common form, affecting approximately 10 to 20 percent of people with multiple sclerosis. This form is characterized by constant symptoms that worsen over time, with no clinical attacks or remissions. Primary progressive MS typically begins later than the other forms, around age 40. Progressive relapsing MS is a rare form of multiple sclerosis that initially appears like primary progressive MS, with constant symptoms. However, people with progressive relapsing MS also experience clinical attacks of more severe symptoms.

MalaCards based summary : Multiple Sclerosis, also known as ms, is related to multiple sclerosis 3 and pediatric multiple sclerosis, and has symptoms including seizures, tremor and back pain. An important gene associated with Multiple Sclerosis is PDCD1 (Programmed Cell Death 1), and among its related pathways/superpathways are Cell adhesion molecules (CAMs) and MicroRNAs in cancer. The drugs acetic acid and Dinoprostone have been mentioned in the context of this disorder. Affiliated tissues include Neural Tube and Limb, and related phenotypes are spasticity and diplopia

Disease Ontology : 12 A demyelinating disease that involves damage to the fatty myelin sheaths around the axons of the brain and spinal cord resulting in demyelination and scarring.

NIH Rare Diseases : 52 Multiple sclerosis (MS) is a degenerative disorder that affects the central nervous system , specifically the brain and the spinal cord. The disorder is characterized by destruction of the myelin , the fatty tissue that surrounds and protects the nerve fibers and promotes the transmission of nerve impulses, and damage to nerve cells . The symptoms vary widely from person to person, and may include sensory disturbances in the limbs, problems with muscle control, tremors, muscle stiffness (spasticity ), exaggerated reflexes (hyperreflexia), weakness, difficulty walking, poor bladder control, and vision problems. Most patients have periods during which they have symptoms (clinical attacks). The clinical attacks are typically followed by periods without any symptoms (remission ). After several years, the symptoms worsen continuously. Multiple sclerosis is considered an autoimmune disorder but the exact cause is unknown. Risk factors for developing multiple sclerosis include genetic factors like changes in the HLA-DRB1 gene and in the IL7R gene and environmental factors , such as exposure to the Epstein-Barr virus , low levels of vitamin D, and smoking. The goal of treatment of MS is to decrease attacks and the inflammation within the central nervous system.

OMIM : 56 Multiple sclerosis (MS) is a chronic inflammatory demyelinating disorder of the central nervous system (CNS) with various degrees of axonal damage. MS affects mainly young adults with predominance for females. The disorder often leads to substantial disability (summary by Bomprezzi et al., 2003). (126200)

MedlinePlus : 42 Multiple sclerosis (MS) is a nervous system disease that affects your brain and spinal cord. It damages the myelin sheath, the material that surrounds and protects your nerve cells. This damage slows down or blocks messages between your brain and your body, leading to the symptoms of MS. They can include Visual disturbances Muscle weakness Trouble with coordination and balance Sensations such as numbness, prickling, or "pins and needles" Thinking and memory problems No one knows what causes MS. It may be an autoimmune disease, which happens when your immune system attacks healthy cells in your body by mistake. Multiple sclerosis affects women more than men. It often begins between the ages of 20 and 40. Usually, the disease is mild, but some people lose the ability to write, speak, or walk. There is no single test for MS. Doctors use a medical history, physical exam, neurological exam, MRI, and other tests to diagnose it. There is no cure for MS, but medicines may slow it down and help control symptoms. Physical and occupational therapy may also help. NIH: National Institute of Neurological Disorders and Stroke

NINDS : 53 An unpredictable disease of the central nervous system, multiple sclerosis (MS) can range from relatively benign to somewhat disabling to devastating, as communication between the brain and other parts of the body is disrupted.  Many investigators believe MS to be an autoimmune disease -- one in which the body, through its immune system, launches a defensive attack against its own tissues. In the case of MS, it is the nerve-insulating myelin that comes under assault. Such assaults may be linked to an unknown environmental trigger, perhaps a virus. Most people experience their first symptoms of MS between the ages of 20 and 40; the initial symptom of MS is often blurred or double vision, red-green color distortion, or even blindness in one eye.  Most MS patients experience muscle weakness in their extremities and difficulty with coordination and balance.  These symptoms may be severe enough to impair walking or even standing. In the worst cases, MS can produce partial or complete paralysis.  Most people with MS also exhibit paresthesias, transitory abnormal sensory feelings such as numbness, prickling, or "pins and needles" sensations.  Some may also experience pain.  Speech impediments, tremors, and dizziness are other frequent complaints. Occasionally, people with MS have hearing loss. Approximately half of all people with MS experience cognitive impairments such as difficulties with concentration, attention, memory, and poor judgment, but such symptoms are usually mild and are frequently overlooked.  Depression is another common feature of MS.

KEGG : 36 Multiple Sclerosis (MS) is a chronic disease of the central nervous system (CNS) characterized by inflammation, demyelination and axonal loss. This disease typically strikes young adults, especially women. There are four types of MS according to their relapsing or progressive pattern that include relapsing-remitting (RRMS), secondary progressive (SPMS), primary progressive (PPMS), and progressive relapsing (PRMS). In most patients, the disease has a relapsing-remitting course during the first years. Within 10 years, approximately 50% of patients progress to SPMS. The aetiology of MS is not well understood, but it is likely multifactorial, combining both genetic and environmental factors. Recently, the literature on the risk factors for MS has grown substantially. They indicate that a combination of a genetic predisposition, exposure to Epstein-Barr virus, cigarette smoking, and reduced sunlight exposure/vitamin D levels is involved. Authorized first-line treatments are considered equally effective, and include interferon beta and glatiramer acetate. They are primarily directed against inflammation, and might fail to adequately control disease activity in some patients. In that case, it has been recommended to switch these patients early to a therapy of higher efficacy. Currently, 13 different drugs with ten different active components are licensed in the European Union (EU) and the United States (US) for the treatment of MS.

UniProtKB/Swiss-Prot : 73 Multiple sclerosis: A multifactorial, inflammatory, demyelinating disease of the central nervous system. Sclerotic lesions are characterized by perivascular infiltration of monocytes and lymphocytes and appear as indurated areas in pathologic specimens (sclerosis in plaques). The pathological mechanism is regarded as an autoimmune attack of the myelin sheath, mediated by both cellular and humoral immunity. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia and bladder dysfunction. Genetic and environmental factors influence susceptibility to the disease.

Wikipedia : 74 Multiple sclerosis (MS) is a demyelinating disease in which the insulating covers of nerve cells in the... more...

Related Diseases for Multiple Sclerosis

Diseases in the Multiple Sclerosis family:

Multiple Sclerosis 2 Multiple Sclerosis 3
Multiple Sclerosis 4 Multiple Sclerosis 5
Secondary Progressive Multiple Sclerosis Primary Progressive Multiple Sclerosis

Diseases related to Multiple Sclerosis via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 2135, show less)
# Related Disease Score Top Affiliating Genes
1 multiple sclerosis 3 35.4 MS3 HLA-DRB1
2 pediatric multiple sclerosis 35.0 HLA-DRB1 HLA-DQB1
3 hypersomnia 33.5 HLA-DRB1 HLA-DQB1
4 autoimmune hepatitis 31.8 PDCD1 HLA-DRB1 HLA-DQB1
5 psoriasis 31.0 MIR326 MIR20A MIR17 MIR142 HLA-DRB1
6 central nervous system disease 30.9 MIR223 MIR20A MIR17 MIR142
7 severe cutaneous adverse reaction 30.8 PDCD1 HLA-DRB1 HLA-DQB1
8 primary adrenal insufficiency 30.8 HLA-DRB1 HLA-DQB1
9 primary biliary cirrhosis 30.7 PDCD1 MIR326 MIR223 MIR20A MIR17 HLA-DRB1
10 autoimmune disease of central nervous system 30.7 MIR223 MIR142 HLA-DRB1
11 autoimmune hepatitis type 1 30.7 HLA-DRB1 HLA-DQB1
12 pityriasis rosea 30.5 HLA-DRB1 HLA-DQB1
13 connective tissue disease 30.5 MIR223 MIR20A MIR17 MIR142 HLA-DRB1
14 nervous system disease 30.2 MIR96 MIR223 MIR20A MIR17 MIR145 MIR142
15 rectum cancer 30.1 MIR20A MIR17 MIR145
16 oral squamous cell carcinoma 30.1 MIR96 MIR223 MIR17 MIR145
17 esophageal disease 30.0 MIR223 MIR17 MIR145 MIR142
18 endometriosis 30.0 MIR223 MIR20A MIR145 MIR142
19 diffuse large b-cell lymphoma 29.9 PDCD1 MIR17 MIR145 MIR142
20 prostate disease 29.9 MIR20A MIR17 MIR145 MIR142
21 thyroid gland disease 29.9 MIR96 MIR17 MIR142
22 inherited metabolic disorder 29.9 MIR20B MIR17 MIR142
23 leukemia, chronic lymphocytic 29.8 MIR223 MIR20A MIR17 MIR145 MIR142
24 pancreatic ductal adenocarcinoma 29.8 MIR96 MIR223 MIR145 MIR142
25 gastrointestinal system disease 29.8 MIR223 MIR20A MIR17 MIR145 MIR142
26 arteries, anomalies of 29.6 MIR223 MIR17 MIR145 MIR142
27 breast disease 29.5 MIR20A MIR17 MIR145 MIR142
28 intestinal disease 29.3 MIR223 MIR20A MIR17 MIR145 MIR142
29 cardiovascular system disease 29.1 MIR223 MIR17 MIR145 MIR142
30 large intestine cancer 29.1 MIR223 MIR20A MIR17 MIR145 MIR142
31 relapsing-remitting multiple sclerosis 12.8
32 marburg acute multiple sclerosis 12.8
33 secondary progressive multiple sclerosis 12.7
34 primary progressive multiple sclerosis 12.7
35 multiple sclerosis 5 12.7
36 progressive relapsing multiple sclerosis 12.6
37 multiple sclerosis 2 12.4
38 multiple sclerosis 4 12.4
39 multiple sclerosis-ichthyosis-factor viii deficiency syndrome 12.2
40 neuromyelitis optica 12.2
41 balo concentric sclerosis 12.1
42 leukodystrophy, demyelinating, adult-onset, autosomal dominant 12.1
43 autosomal dominant leukodystrophy with autonomic disease 11.9
44 optic neuritis 11.9
45 allergic encephalomyelitis 11.7
46 trigeminal neuralgia 11.7
47 spasticity 11.6
48 progressive multifocal leukoencephalopathy 11.6
49 leber optic atrophy 11.6
50 pars planitis 11.6
51 malonyl-coa decarboxylase deficiency 11.5
52 tremor 11.5
53 brown-sequard syndrome 11.5
54 acute disseminated encephalomyelitis 11.5
55 rickets 11.5
56 optic nerve disease 11.5
57 cerebral atrophy 11.5
58 neurogenic bladder 11.5
59 dysphagia 11.5
60 paresthesia 11.5
61 intermediate uveitis 11.4
62 pseudobulbar affect 11.4
63 foot drop 11.4
64 retinal vasculitis 11.4
65 myoclonus 11.4
66 cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 11.4
67 locked-in syndrome 11.4
68 neurogenic bowel 11.4
69 hypertonia 11.4
70 stiff-person syndrome 11.4
71 spinocerebellar degeneration 11.4
72 swallowing disorders 11.4
73 cerebellar degeneration 11.4
74 myelinoclastic diffuse sclerosis 11.4
75 leukoencephalopathy, hereditary diffuse, with spheroids 11.4
76 glossopharyngeal neuralgia 11.4
77 alexander disease 11.4
78 postinfectious encephalomyelitis 11.4
79 thoracic outlet syndrome 11.4
80 adult acute lymphocytic leukemia 11.3
81 central pain syndrome 11.2
82 demyelinating disease 11.2
83 autoimmune disease 11.2
84 neuritis 11.1
85 thanatophoric dysplasia, type ii 11.1
86 bile acid synthesis defect, congenital, 2 11.1
87 methylmalonic aciduria and homocystinuria, cbld type 11.1
88 lathosterolosis 11.1
89 bile acid synthesis defect, congenital, 1 11.1
90 short qt syndrome 1 11.1
91 short qt syndrome 2 11.1
92 short qt syndrome 3 11.1
93 aminoacylase 1 deficiency 11.1
94 short qt syndrome 11.1
95 syndromic x-linked intellectual disability snyder type 11.1
96 autoimmune disease 6 11.1
97 combined malonic and methylmalonic aciduria 11.1
98 patulous eustachian tube 11.1
99 chiasmal syndrome 11.1
100 developmental coordination disorder 11.1
101 ataxias and cerebellar or spinocerebellar degeneration 11.1
102 immune-mediated encephalomyelitis 11.1
103 spinocerebellar atrophy 11.1
104 limbic encephalitis with lgi1 antibodies 11.0 HLA-DRB1 HLA-DQB1
105 autoimmune polyglandular syndrome type 3 11.0 HLA-DRB1 HLA-DQB1
106 narcolepsy 2 10.9 HLA-DRB1 HLA-DQB1
107 type ii mixed cryoglobulinemia 10.9 HLA-DRB1 HLA-DQB1
108 moyamoya angiopathy 10.9 HLA-DRB1 HLA-DQB1
109 recurrent respiratory papillomatosis 10.9 HLA-DRB1 HLA-DQB1
110 beryllium disease 10.9 HLA-DRB1 HLA-DQB1
111 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 10.9
112 apple allergy 10.9 HLA-DRB1 HLA-DQB1
113 chronic beryllium disease 10.9 HLA-DRB1 HLA-DQB1
114 focal epithelial hyperplasia 10.9 HLA-DRB1 HLA-DQB1
115 metal allergy 10.9 HLA-DRB1 HLA-DQB1
116 measles 10.9
117 osteonecrosis of the jaw 10.9 HLA-DRB1 HLA-DQB1
118 narcolepsy 1 10.8 HLA-DRB1 HLA-DQB1
119 idiopathic bronchiectasis 10.8 HLA-DRB1 HLA-DQB1
120 red cell aplasia 10.8 HLA-DRB1 HLA-DQB1
121 ataxia and polyneuropathy, adult-onset 10.7
122 venous insufficiency 10.7
123 cytokine deficiency 10.7
124 sexual disorder 10.7
125 depression 10.7
126 myelitis 10.7
127 chickenpox 10.7
128 oligoarticular juvenile idiopathic arthritis 10.6 HLA-DRB1 HLA-DQB1
129 lateral sclerosis 10.6
130 amyotrophic lateral sclerosis 1 10.6
131 pathologic nystagmus 10.6
132 rubella 10.6
133 encephalitis 10.6
134 migraine with or without aura 1 10.6
135 lymphopenia 10.6
136 neuropathy 10.6
137 uveitis 10.6
138 neuromyelitis optica spectrum disorder 10.6
139 whipple disease 10.6 HLA-DRB1 HLA-DQB1
140 anxiety 10.6
141 subacute sclerosing panencephalitis 10.6
142 sleep disorder 10.6
143 transverse myelitis 10.6
144 mood disorder 10.5
145 myasthenia gravis 10.5
146 spinal cord injury 10.5
147 autonomic dysfunction 10.5
148 visual epilepsy 10.5
149 seizure disorder 10.5
150 kearns-sayre syndrome 10.5
151 pfeiffer syndrome 10.5
152 mumps 10.5
153 vasculitis 10.5
154 headache 10.5
155 systemic lupus erythematosus 10.5
156 chronic pain 10.5
157 47,xyy 10.5
158 meester-loeys syndrome 10.5
159 herpes simplex 10.5
160 chlamydia 10.5
161 internuclear ophthalmoplegia 10.5
162 acute retrobulbar neuritis 10.5
163 spastic paraparesis 10.5
164 movement disease 10.5
165 chronic fatigue syndrome 10.5
166 autoimmune encephalitis 10.5
167 bone inflammation disease 10.5 MIR223 MIR17 MIR142 HLA-DRB1
168 chlamydia pneumonia 10.5
169 guillain-barre syndrome 10.5
170 constipation 10.4
171 pustulosis of palm and sole 10.4
172 lupus erythematosus 10.4
173 pik3ca-related overgrowth syndrome 10.4
174 proteasome-associated autoinflammatory syndrome 1 10.4
175 mental depression 10.4
176 dystonia 10.4
177 alzheimer disease 10.4
178 inflammatory bowel disease 10.4
179 restless legs syndrome 10.4
180 tetanus 10.4
181 epilepsy 10.4
182 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.4
183 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 10.4
184 paraplegia 10.4
185 polyneuropathy 10.4
186 impotence 10.4
187 bipolar disorder 10.4
188 major affective disorder 8 10.4
189 major affective disorder 9 10.4
190 low compliance bladder 10.4
191 herpes zoster 10.4
192 neutropenia 10.4
193 acute cystitis 10.4
194 encephalopathy 10.4
195 narcolepsy 10.4
196 major depressive disorder 10.4
197 hereditary optic neuropathy 10.4
198 peripheral nervous system disease 10.4
199 ocular cicatricial pemphigoid 10.4 HLA-DRB1 HLA-DQB1
200 crohn's disease 10.4
201 wallerian degeneration 10.4
202 exanthem 10.4
203 vascular disease 10.4
204 hepatitis b 10.4
205 macular retinal edema 10.4
206 aphasia 10.3
207 48,xyyy 10.3
208 candidiasis, familial, 1 10.3
209 body mass index quantitative trait locus 1 10.3
210 hypothyroidism 10.3
211 sarcoidosis 1 10.3
212 branchiootic syndrome 1 10.3
213 thyroiditis 10.3
214 dentinogenesis imperfecta type 2 10.3
215 meningoencephalitis 10.3
216 aceruloplasminemia 10.3
217 hydrops, lactic acidosis, and sideroblastic anemia 10.3
218 meningitis 10.3
219 retinitis pigmentosa 18 10.3
220 parkinson disease, late-onset 10.3
221 rheumatoid arthritis 10.3
222 facial paralysis 10.3
223 thrombocytopenia 10.3
224 purpura 10.3
225 severe combined immunodeficiency 10.3
226 laryngeal disease 10.3 MIR20A MIR17 MIR142
227 intestinal benign neoplasm 10.3 MIR20A MIR17 MIR142
228 huntington disease 10.3
229 sleep apnea 10.3
230 lymphoma 10.3
231 inflammatory spondylopathy 10.3
232 detrusor sphincter dyssynergia 10.3
233 antiphospholipid syndrome 10.3
234 tropical spastic paraparesis 10.3
235 spondylitis 10.3
236 infratentorial cancer 10.3 MIR20A MIR17 MIR142
237 gastrointestinal system benign neoplasm 10.3 MIR20A MIR17 MIR142
238 spondyloarthropathy 1 10.3
239 myelopathy, htlv-1-associated 10.3
240 pertussis 10.3
241 lyme disease 10.3
242 allergic hypersensitivity disease 10.3
243 amenorrhea 10.3
244 poliomyelitis 10.3
245 htlv-1 associated myelopathy/tropical spastic paraparesis 10.3
246 bile duct disease 10.3 MIR17 MIR145 MIR142
247 yemenite deaf-blind hypopigmentation syndrome 10.3
248 chronic inflammatory demyelinating polyradiculoneuropathy 10.3
249 glial tumor 10.3
250 status epilepticus 10.3
251 vaccinia 10.3
252 demyelinating polyneuropathy 10.3
253 cerebrovascular disease 10.3
254 alopecia 10.3
255 glioma 10.3
256 dementia - subcortical 10.3
257 feingold syndrome 1 10.3 MIR20A MIR18B MIR17
258 thrombophilia due to thrombin defect 10.3
259 hydrocephalus 10.3
260 osteoporosis 10.3
261 celiac disease 1 10.3
262 bone mineral density quantitative trait locus 8 10.3
263 bone mineral density quantitative trait locus 15 10.3
264 atrioventricular block 10.3
265 leukodystrophy 10.3
266 aseptic meningitis 10.3
267 astrocytoma 10.3
268 traumatic brain injury 10.3
269 paroxysmal dystonia 10.3
270 ovarian cancer 10.3
271 gallbladder disease 10.3 MIR17 MIR145 MIR142
272 biliary tract disease 10.3 MIR17 MIR145 MIR142
273 respiratory failure 10.3
274 ulcerative colitis 10.3
275 isolated optic neuritis 10.3
276 apraxia 10.2
277 sensorineural hearing loss 10.2
278 bullous pemphigoid 10.2
279 bacterial infectious disease 10.2
280 hemiplegia 10.2
281 graves' disease 10.2
282 dementia 10.2
283 rare surgical neurologic disease 10.2
284 syringomyelia, noncommunicating isolated 10.2
285 aging 10.2
286 vitamin b12 deficiency 10.2
287 quadriplegia 10.2
288 thrombocytopenia due to platelet alloimmunization 10.2
289 glioblastoma multiforme 10.2
290 syringomyelia 10.2
291 fibromyalgia 10.2
292 pancreatic cancer 10.2
293 malignant ovarian surface epithelial-stromal neoplasm 10.2 MIR18B MIR17 MIR145
294 alexithymia 10.2
295 back pain 10.2
296 cerebrofacial arteriovenous metameric syndrome 10.2
297 ovary epithelial cancer 10.2 MIR18B MIR17 MIR145
298 scleroderma, familial progressive 10.2
299 familial mediterranean fever 10.2
300 3-methylglutaconic aciduria, type iii 10.2
301 stroke, ischemic 10.2
302 motor neuron disease 10.2
303 spinal cord disease 10.2
304 viral encephalitis 10.2
305 hyperthyroidism 10.2
306 iridocyclitis 10.2
307 seizures, benign familial neonatal, 1 10.2
308 neurofibromatosis, type iv, of riccardi 10.2
309 argyria 10.2
310 pharynx cancer 10.2 MIR17 MIR145 MIR142
311 lymphocytic leukemia 10.2
312 hepatitis 10.2
313 psychotic disorder 10.2
314 oligodendroglioma 10.2
315 adrenomyeloneuropathy 10.2
316 hashimoto thyroiditis 10.2
317 schizophrenia 10.2
318 personality disorder 10.2
319 cerebral palsy 10.2
320 lung disease 10.2
321 hypereosinophilic syndrome 10.2
322 brain injury 10.2
323 connective tissue cancer 10.2 MIR223 MIR20A MIR17 MIR142
324 glucose metabolism disease 10.2 MIR223 MIR20A MIR17 MIR142
325 multiple self-healing squamous epithelioma 10.2
326 hyperprolactinemia 10.2
327 colitis 10.2
328 pulmonary edema 10.2
329 neurosarcoidosis 10.2
330 central nervous system lymphoma 10.2
331 head injury 10.2
332 acquired metabolic disease 10.1 MIR223 MIR20A MIR17 MIR142
333 fatty liver disease 10.1
334 upper respiratory tract disease 10.1 MIR20A MIR17 MIR142
335 adrenoleukodystrophy 10.1
336 body mass index quantitative trait locus 11 10.1
337 chorea, childhood-onset, with psychomotor retardation 10.1
338 amnestic disorder 10.1
339 choreatic disease 10.1
340 diarrhea 10.1
341 panniculitis 10.1
342 alcohol use disorder 10.1
343 rheumatic disease 10.1
344 dysgraphia 10.1
345 congestive heart failure 10.1
346 b-cell lymphoma 10.1
347 t-cell leukemia 10.1
348 influenza 10.1
349 primary central nervous system lymphoma 10.1
350 acute transverse myelitis 10.1
351 leukocyte disease 10.1 MIR20A MIR17 MIR145 MIR142
352 uterine anomalies 10.1 MIR20B MIR17 MIR145 MIR142
353 methylmalonic acidemia 10.1
354 colonic disease 10.1 MIR20A MIR17 MIR145 MIR142
355 alcohol dependence 10.1
356 ocular motor apraxia 10.1
357 sjogren syndrome 10.1
358 helicobacter pylori infection 10.1
359 hepatitis c virus 10.1
360 deficiency anemia 10.1
361 aspiration pneumonia 10.1
362 nasopharyngitis 10.1
363 hemosiderosis 10.1
364 acute leukemia 10.1
365 disease of mental health 10.1
366 spondylosis 10.1
367 myopathy 10.1
368 polyradiculoneuropathy 10.1
369 acquired immunodeficiency syndrome 10.1
370 rem sleep behavior disorder 10.1
371 diabetes mellitus 10.1
372 intracranial hypertension 10.1
373 rare hereditary hemochromatosis 10.1
374 cervix disease 10.1 MIR18B MIR17 MIR145 MIR142
375 nervous system cancer 10.1 MIR20A MIR17 MIR145 MIR142
376 stomach disease 10.1 MIR20A MIR17 MIR145 MIR142
377 mucopolysaccharidosis-plus syndrome 10.1
378 obsessive-compulsive disorder 10.1
379 immune deficiency disease 10.1
380 primrose syndrome 10.1
381 body mass index quantitative trait locus 9 10.1
382 body mass index quantitative trait locus 8 10.1
383 meningioma, radiation-induced 10.1
384 meningioma, familial 10.1
385 body mass index quantitative trait locus 4 10.1
386 body mass index quantitative trait locus 10 10.1
387 body mass index quantitative trait locus 7 10.1
388 body mass index quantitative trait locus 12 10.1
389 body mass index quantitative trait locus 14 10.1
390 body mass index quantitative trait locus 18 10.1
391 body mass index quantitative trait locus 19 10.1
392 body mass index quantitative trait locus 20 10.1
393 pain agnosia 10.1
394 agraphia 10.1
395 spinal meningioma 10.1
396 panuveitis 10.1
397 leukemia 10.1
398 skin carcinoma 10.1
399 systemic scleroderma 10.1
400 secretory meningioma 10.1
401 lymphoplasmacyte-rich meningioma 10.1
402 essential tremor 10.1
403 muscular dystrophy 10.1
404 dysautonomia 10.1
405 thrombotic microangiopathy 10.1
406 autonomic nervous system neoplasm 10.1 MIR20A MIR17 MIR142
407 prostatic hyperplasia, benign 10.1
408 prostatic adenoma 10.1
409 isolated methylmalonic acidemia 10.1
410 phenylketonuria 10.1
411 non-alcoholic fatty liver disease 10.1
412 dysentery 10.1
413 mucopolysaccharidoses 10.1
414 hypercholesterolemia, familial, 1 10.1
415 spondylosis, cervical 10.1
416 triiodothyronine receptor auxiliary protein 10.1
417 lymphoma, hodgkin, classic 10.1
418 fabry disease 10.1
419 bone mineral density quantitative trait locus 3 10.1
420 microvascular complications of diabetes 5 10.1
421 thrombosis 10.1
422 asymptomatic neurosyphilis 10.1
423 avoidant personality disorder 10.1
424 enthesopathy 10.1
425 dental caries 10.1
426 dermatitis 10.1
427 neuromuscular disease 10.1
428 infertility 10.1
429 neurosyphilis 10.1
430 pure autonomic failure 10.1
431 sudden sensorineural hearing loss 10.1
432 peripheral nervous system neoplasm 10.1 MIR20A MIR17 MIR142
433 atrial standstill 1 10.1
434 major affective disorder 1 10.1
435 orthostatic intolerance 10.1
436 human immunodeficiency virus type 1 10.1
437 acute promyelocytic leukemia 10.1
438 cervical dystonia 10.1
439 neuroretinitis 10.1
440 charcot-marie-tooth disease 10.1
441 diphtheria 10.1
442 color blindness 10.1
443 alexia 10.1
444 urticaria 10.1
445 retinal vascular disease 10.1
446 radiculopathy 10.1
447 hemolytic anemia 10.1
448 juvenile rheumatoid arthritis 10.1
449 scotoma 10.1
450 viral infectious disease 10.1
451 bacterial meningitis 10.1
452 pulmonary embolism 10.1
453 cluster headache 10.1
454 inflammatory myopathy with abundant macrophages 10.1
455 pachyonychia congenita 3 10.1
456 tyrosinemia 10.1
457 ovarian epithelial cancer 10.1
458 acyl-coa dehydrogenase deficiency 10.1
459 creutzfeldt-jakob disease 10.0
460 hand skill, relative 10.0
461 pulmonary hypertension, primary, 1 10.0
462 taqi polymorphism 10.0
463 leukemia, acute myeloid 10.0
464 intraocular pressure quantitative trait locus 10.0
465 tick-borne encephalitis 10.0
466 lymphoproliferative syndrome 10.0
467 viral meningitis 10.0
468 hydronephrosis 10.0
469 pyelonephritis 10.0
470 nephrotic syndrome 10.0
471 bell's palsy 10.0
472 migraine without aura 10.0
473 generalized anxiety disorder 10.0
474 hepatitis c 10.0
475 hyperinsulinism 10.0
476 syphilis 10.0
477 muscular atrophy 10.0
478 speech disorder 10.0
479 irritable bowel syndrome 10.0
480 hypoxia 10.0
481 syncope 10.0
482 acute liver failure 10.0
483 prostate cancer 10.0
484 hemifacial spasm, familial 10.0
485 thrombocytopenic purpura, autoimmune 10.0
486 torticollis 10.0
487 vitiligo-associated multiple autoimmune disease susceptibility 6 10.0
488 vitiligo-associated multiple autoimmune disease susceptibility 1 10.0
489 psoriatic arthritis 10.0
490 graft-versus-host disease 10.0
491 crohn's colitis 10.0
492 bone resorption disease 10.0
493 physical disorder 10.0
494 tooth disease 10.0
495 horner's syndrome 10.0
496 gout 10.0
497 cerebellar disease 10.0
498 neurotic disorder 10.0
499 scrapie 10.0
500 raynaud phenomenon 10.0
501 hemifacial spasm 10.0
502 propionic acidemia 10.0
503 invasive aspergillosis 10.0
504 opioid abuse 10.0
505 polycystic ovary syndrome 10.0
506 adenocarcinoma 10.0
507 oral cancer 10.0
508 kaposi sarcoma 10.0
509 graves disease 1 10.0
510 homocysteinemia 10.0
511 leukemia, acute lymphoblastic 10.0
512 leukemia, acute lymphoblastic 3 10.0
513 spinal disease 10.0
514 optic papillitis 10.0
515 pre-eclampsia 10.0
516 thrombotic thrombocytopenic purpura 10.0
517 brucellosis 10.0
518 rabies 10.0
519 arteriovenous malformation 10.0
520 posterior uveitis 10.0
521 cystitis 10.0
522 viral hepatitis 10.0
523 iron metabolism disease 10.0
524 hereditary spastic paraplegia 10.0
525 sensory peripheral neuropathy 10.0
526 substance abuse 10.0
527 ischemia 10.0
528 retinitis 10.0
529 agnosia 10.0
530 eye disease 10.0
531 placenta disease 10.0
532 cataract 10.0
533 arthritis 10.0
534 subacute delirium 10.0
535 myeloid leukemia 10.0
536 polyarteritis nodosa 10.0
537 mitochondrial disorders 10.0
538 broken heart syndrome 10.0
539 herpes simplex encephalitis 10.0
540 polymyositis 10.0
541 cytomegalovirus infection 10.0
542 mastitis 10.0
543 urinary system disease 10.0 MIR223 MIR20B MIR17 MIR145 MIR142
544 gonadal disease 10.0 MIR223 MIR20A MIR17 MIR145 MIR142
545 male reproductive organ cancer 10.0 MIR223 MIR20A MIR17 MIR145 MIR142
546 male reproductive system disease 10.0 MIR223 MIR20A MIR17 MIR145 MIR142
547 esophageal cancer 10.0
548 maple syrup urine disease 10.0
549 foodborne botulism 10.0
550 sleeping sickness 10.0
551 soft tissue sarcoma 10.0
552 obsolete: atypical teratoid/rhabdoid tumor 10.0
553 reproductive system disease 10.0 MIR223 MIR20A MIR17 MIR145 MIR142
554 female reproductive system disease 10.0 MIR223 MIR20A MIR17 MIR145 MIR142
555 respiratory system cancer 10.0 MIR223 MIR20A MIR17 MIR145 MIR142
556 thoracic cancer 10.0 MIR223 MIR20A MIR17 MIR145 MIR142
557 respiratory system disease 10.0 MIR223 MIR20A MIR17 MIR145 MIR142
558 gastrointestinal system cancer 10.0 MIR223 MIR20A MIR17 MIR145 MIR142
559 atherosclerosis susceptibility 10.0
560 multiple system atrophy 1 10.0
561 neurofibromatosis, type i 10.0
562 nephrolithiasis, calcium oxalate 10.0
563 anemia, autoimmune hemolytic 10.0
564 diabetes mellitus, insulin-dependent 10.0
565 hemochromatosis, type 1 10.0
566 nasopharyngeal carcinoma 10.0
567 resting heart rate, variation in 10.0
568 coronary heart disease 1 10.0
569 myelodysplastic syndrome 10.0
570 ptosis 10.0
571 t cell deficiency 10.0
572 dysthymic disorder 10.0
573 retinal ischemia 10.0
574 toxic shock syndrome 10.0
575 bacteriuria 10.0
576 normal pressure hydrocephalus 10.0
577 melanoma 10.0
578 hypogonadism 10.0
579 tic disorder 10.0
580 newcastle disease 10.0
581 liver cirrhosis 10.0
582 combined t cell and b cell immunodeficiency 10.0
583 hypogonadotropism 10.0
584 diabetes insipidus 10.0
585 yellow fever 10.0
586 toxoplasmosis 10.0
587 aids dementia complex 10.0
588 haemophilus influenzae 10.0
589 human t-cell leukemia virus type 1 10.0
590 specific language disorder 10.0
591 benign idiopathic neonatal seizures 10.0
592 overgrowth syndrome 10.0
593 cell type cancer 10.0 MIR223 MIR20A MIR17 MIR145 MIR142
594 hypertension, essential 9.9
595 acyl-coa dehydrogenase, medium-chain, deficiency of 9.9
596 isovaleric acidemia 9.9
597 fatty liver disease, nonalcoholic 1 9.9
598 carbonic anhydrase va deficiency, hyperammonemia due to 9.9
599 trypanosomiasis 9.9
600 silicosis 9.9
601 common cold 9.9
602 opiate dependence 9.9
603 abducens palsy 9.9
604 ige responsiveness, atopic 9.9
605 papillomatosis, confluent and reticulated 9.9
606 complement component 2 deficiency 9.9
607 kuru 9.9
608 metachromatic leukodystrophy 9.9
609 insulin-like growth factor i 9.9
610 cd4/cd8 t-cell ratio 9.9
611 pulmonary disease, chronic obstructive 9.9
612 leukemia, chronic myeloid 9.9
613 human herpesvirus 8 9.9
614 interleukin-7 receptor alpha deficiency 9.9
615 cryptococcal meningitis 9.9
616 postural orthostatic tachycardia syndrome 9.9
617 endocarditis 9.9
618 listeriosis 9.9
619 gastroparesis 9.9
620 goiter 9.9
621 pancytopenia 9.9
622 chronic progressive external ophthalmoplegia 9.9
623 keratoconjunctivitis sicca 9.9
624 dissociated nystagmus 9.9
625 porphyria 9.9
626 autosomal dominant cerebellar ataxia 9.9
627 rheumatic fever 9.9
628 conversion disorder 9.9
629 grade iii astrocytoma 9.9
630 lipid metabolism disorder 9.9
631 neurilemmoma 9.9
632 inappropriate adh syndrome 9.9
633 thrombophlebitis 9.9
634 pyoderma 9.9
635 rhinitis 9.9
636 benign ependymoma 9.9
637 cellular ependymoma 9.9
638 kidney disease 9.9
639 panic disorder 9.9
640 adenoma 9.9
641 neuroblastoma 9.9
642 end stage renal failure 9.9
643 collagen disease 9.9
644 vascular dementia 9.9
645 stomatitis 9.9
646 diabetic neuropathy 9.9
647 acquired hemophilia 9.9
648 granulocytopenia 9.9
649 susac syndrome 9.9
650 occipital neuralgia 9.9
651 posttransplant acute limbic encephalitis 9.9
652 paroxysmal dyskinesia 9.9
653 systemic autoimmune disease 9.9
654 avascular necrosis 9.9
655 smith-lemli-opitz syndrome 9.9
656 tyrosinemia, type i 9.9
657 opitz gbbb syndrome, type i 9.9
658 citrullinemia, type ii, adult-onset 9.9
659 autoimmune lymphoproliferative syndrome, type v 9.9
660 metabolic acidosis 9.9
661 organic acidemia 9.9
662 multidrug-resistant tuberculosis 9.9
663 anthrax disease 9.9
664 peroxisomal disease 9.9
665 ciguatera fish poisoning 9.9
666 mycobacterium abscessus 9.9
667 hematologic cancer 9.9 MIR223 MIR20A MIR17 MIR145 MIR142
668 aortic aneurysm, familial abdominal, 1 9.9
669 acyl-coa dehydrogenase, short-chain, deficiency of 9.9
670 galactosemia 9.9
671 epilepsy, pyridoxine-dependent 9.9
672 microvascular complications of diabetes 1 9.9
673 microvascular complications of diabetes 2 9.9
674 aortic aneurysm 9.9
675 pancreatic adenocarcinoma 9.9
676 avian influenza 9.9
677 medium-chain acyl-coenzyme a dehydrogenase deficiency 9.9
678 disseminated infection with mycobacterium avium complex 9.9
679 bladder cancer 9.9
680 burkitt lymphoma 9.9
681 deafness, unilateral 9.9
682 episodic kinesigenic dyskinesia 1 9.9
683 pernicious anemia 9.9
684 pelvic organ prolapse 9.9
685 retinal detachment 9.9
686 spinal arachnoiditis 9.9
687 vesicoureteral reflux 1 9.9
688 galactorrhea 9.9
689 biotinidase deficiency 9.9
690 reticulum cell sarcoma 9.9
691 pelizaeus-merzbacher disease 9.9
692 frontotemporal dementia 9.9
693 lymphoma, non-hodgkin, familial 9.9
694 myocardial infarction 9.9
695 membranous nephropathy 9.9
696 glucocorticoid resistance, generalized 9.9
697 adult t-cell leukemia 9.9
698 second-degree atrioventricular block 9.9
699 immunoglobulin alpha deficiency 9.9
700 cutaneous t cell lymphoma 9.9
701 atrial fibrillation 9.9
702 nodal marginal zone lymphoma 9.9
703 migraine with aura 9.9
704 osteonecrosis 9.9
705 abducens nerve disease 9.9
706 sarcoma 9.9
707 heart disease 9.9
708 choroiditis 9.9
709 gestational diabetes 9.9
710 cryptococcosis 9.9
711 arachnoiditis 9.9
712 pseudobulbar palsy 9.9
713 telangiectasis 9.9
714 transient global amnesia 9.9
715 brain cancer 9.9
716 pulmonary sarcoidosis 9.9
717 eclampsia 9.9
718 premature ejaculation 9.9
719 squamous cell papilloma 9.9
720 obstructive hydrocephalus 9.9
721 endogenous depression 9.9
722 pericarditis 9.9
723 gastroenteritis 9.9
724 hemangioma 9.9
725 papilloma 9.9
726 acute pancreatitis 9.9
727 glomerulonephritis 9.9
728 food allergy 9.9
729 cranial nerve palsy 9.9
730 gastritis 9.9
731 spindle cell sarcoma 9.9
732 brain edema 9.9
733 adjustment disorder 9.9
734 blepharospasm 9.9
735 pneumonia 9.9
736 cerebral lymphoma 9.9
737 central pontine myelinolysis 9.9
738 amyloidosis 9.9
739 pemphigus 9.9
740 alopecia areata 9.9
741 hypoglycemia 9.9
742 central serous chorioretinopathy 9.9
743 charles bonnet syndrome 9.9
744 chiari malformation 9.9
745 eales disease 9.9
746 engraftment syndrome 9.9
747 limbic encephalitis 9.9
748 rapidly involuting congenital hemangioma 9.9
749 periodic paralysis 9.9
750 dowling-degos disease 1 9.9
751 retinoblastoma 9.9
752 dihydropyrimidine dehydrogenase deficiency 9.9
753 dengue virus 9.9
754 mantle cell lymphoma 9.9
755 biotin deficiency 9.9
756 ductal carcinoma in situ 9.9
757 estrogen-receptor positive breast cancer 9.9
758 sphingolipidosis 9.9
759 familial retinoblastoma 9.9
760 cocaine abuse 9.9
761 dermatophytosis 9.9
762 zellweger syndrome 9.9
763 creatine deficiency syndromes 9.9
764 cyanide poisoning 9.9
765 motion sickness 9.8
766 osteogenic sarcoma 9.8
767 mucopolysaccharidosis, type ii 9.8
768 citrullinemia, type ii, neonatal-onset 9.8
769 isobutyryl-coa dehydrogenase deficiency 9.8
770 adenine phosphoribosyltransferase deficiency 9.8
771 colorectal adenocarcinoma 9.8
772 chagas disease 9.8
773 colon adenocarcinoma 9.8
774 arteriosclerosis 9.8
775 hemoglobinopathy 9.8
776 multiple carboxylase deficiency 9.8
777 cannabis abuse 9.8
778 congenital disorders of n-linked glycosylation and multiple pathway 9.8
779 homocystinuria caused by cystathionine beta-synthase deficiency 9.8
780 neisseria meningitidis infection 9.8
781 opioid addiction 9.8
782 paraquat poisoning 9.8
783 colchicine poisoning 9.8
784 cerebral amyloid angiopathy, cst3-related 9.8
785 breast cancer 9.8
786 hepatocellular carcinoma 9.8
787 cardiac conduction defect 9.8
788 attention deficit-hyperactivity disorder 9.8
789 renal cell carcinoma, nonpapillary 9.8
790 lipomatosis, multiple 9.8
791 myositis 9.8
792 hypokalemic periodic paralysis, type 1 9.8
793 strabismus 9.8
794 tobacco addiction 9.8
795 autism 9.8
796 lung cancer 9.8
797 cerebrotendinous xanthomatosis 9.8
798 factor vii deficiency 9.8
799 moyamoya disease 1 9.8
800 myeloma, multiple 9.8
801 vitamin d hydroxylation-deficient rickets, type 1a 9.8
802 asthma 9.8
803 autoimmune lymphoproliferative syndrome 9.8
804 xanthomatosis 9.8
805 spastic paraplegia 11, autosomal recessive 9.8
806 acute hemorrhagic leukoencephalitis 9.8
807 allergic rhinitis 9.8
808 kala-azar 1 9.8
809 aspergillosis 9.8
810 encephalopathy, progressive, early-onset, with episodic rhabdomyolysis 9.8
811 speech and communication disorders 9.8
812 peripheral vascular disease 9.8
813 angina pectoris 9.8
814 pulmonary hypertension 9.8
815 hemophagocytic lymphohistiocytosis 9.8
816 swine influenza 9.8
817 first-degree atrioventricular block 9.8
818 hemidystonia 9.8
819 spastic ataxia 9.8
820 anosognosia 9.8
821 cortical deafness 9.8
822 bone disease 9.8
823 cysticercosis 9.8
824 xerophthalmia 9.8
825 pleomorphic lipoma 9.8
826 dermatomyositis 9.8
827 siderosis 9.8
828 tonsillitis 9.8
829 social phobia 9.8
830 listeria meningitis 9.8
831 iron deficiency anemia 9.8
832 myopia 9.8
833 bronchopneumonia 9.8
834 hepatitis a 9.8
835 hemolytic-uremic syndrome 9.8
836 leiomyoma 9.8
837 miller fisher syndrome 9.8
838 focal segmental glomerulosclerosis 9.8
839 ehlers-danlos syndrome 9.8
840 frozen shoulder 9.8
841 neuroleptic malignant syndrome 9.8
842 hyperuricemia 9.8
843 neuroma 9.8
844 post-traumatic stress disorder 9.8
845 focal epilepsy 9.8
846 thrombophilia 9.8
847 basal cell carcinoma 9.8
848 agammaglobulinemia 9.8
849 bruxism 9.8
850 hairy cell leukemia 9.8
851 bursitis 9.8
852 acute kidney failure 9.8
853 churg-strauss syndrome 9.8
854 gingivitis 9.8
855 complex regional pain syndrome 9.8
856 histiocytosis 9.8
857 plexopathy 9.8
858 skin disease 9.8
859 pituitary adenoma 9.8
860 merkel cell carcinoma 9.8
861 liver disease 9.8
862 mutism 9.8
863 dyslexia 9.8
864 postpoliomyelitis syndrome 9.8
865 gerstmann syndrome 9.8
866 borna disease 9.8
867 central nervous system vasculitis 9.8
868 schizoaffective disorder 9.8
869 acute stress disorder 9.8
870 mitochondrial metabolism disease 9.8
871 subacute thyroiditis 9.8
872 axonal neuropathy 9.8
873 chronic kidney disease 9.8
874 myocarditis 9.8
875 periodontitis 9.8
876 ileus 9.8
877 paralytic ileus 9.8
878 retinal degeneration 9.8
879 reticulosarcoma 9.8
880 pyoderma gangrenosum 9.8
881 decubitus ulcer 9.8
882 leishmaniasis 9.8
883 periodic limb movement disorder 9.8
884 central sleep apnea 9.8
885 ocular hypertension 9.8
886 priapism 9.8
887 mechanical strabismus 9.8
888 allergic angiitis 9.8
889 chronic graft versus host disease 9.8
890 mast cell activation syndrome 9.8
891 oligoastrocytoma 9.8
892 primary angiitis of the central nervous system 9.8
893 reversible cerebral vasoconstriction syndrome 9.8
894 tuberculous meningitis 9.8
895 x-linked charcot-marie-tooth disease 9.8
896 color vision deficiency 9.8
897 aneurysm 9.8
898 anoxia 9.8
899 hypotonia 9.8
900 meningitis and encephalitis 9.8
901 myotonia 9.8
902 superficial siderosis 9.8
903 cranial neuralgia 9.8
904 hypocalcemic vitamin d-dependent rickets 9.8
905 chronic enteropathy associated with slco2a1 gene 9.8
906 persistent idiopathic facial pain 9.8
907 chronic encephalitis 9.8
908 cardiogenic shock 9.8
909 thyroid carcinoma 9.8
910 beckwith-wiedemann syndrome 9.8
911 neural tube defects 9.8
912 thyroid cancer, nonmedullary, 1 9.8
913 adrenocortical carcinoma, hereditary 9.8
914 apparent mineralocorticoid excess 9.8
915 hydrops fetalis, nonimmune 9.8
916 n-acetylglutamate synthase deficiency 9.8
917 autoimmune polyendocrine syndrome, type i, with or without reversible metaphyseal dysplasia 9.8
918 galactosialidosis 9.8
919 pancreatic agenesis 1 9.8
920 ornithine transcarbamylase deficiency, hyperammonemia due to 9.8
921 2-methylbutyryl-coa dehydrogenase deficiency 9.8
922 pyridoxamine 5-prime-phosphate oxidase deficiency 9.8
923 cerebral creatine deficiency syndrome 2 9.8
924 melioidosis 9.8
925 adrenal cortical carcinoma 9.8
926 chikungunya 9.8
927 inhalation anthrax 9.8
928 chronic venous insufficiency 9.8
929 idiopathic scoliosis 9.8
930 peroxisomal biogenesis disorder 9.8
931 osteomyelitis 9.8
932 pleurisy 9.8
933 asbestosis 9.8
934 lactose intolerance 9.8
935 methemoglobinemia 9.8
936 filariasis 9.8
937 familial hyperlipidemia 9.8
938 biliary atresia 9.8
939 dumping syndrome 9.8
940 larynx cancer 9.8
941 pancreas disease 9.8
942 periarthritis 9.8
943 breast adenocarcinoma 9.8
944 adrenal cortical adenocarcinoma 9.8
945 thyroid gland papillary carcinoma 9.8
946 mouth disease 9.8
947 endophthalmitis 9.8
948 amphetamine abuse 9.8
949 peptic ulcer disease 9.8
950 cervix uteri carcinoma in situ 9.8
951 acid sphingomyelinase deficiency 9.8
952 cervical intraepithelial neoplasia 9.8
953 ring chromosome 13 9.8
954 systemic onset juvenile idiopathic arthritis 9.8
955 asbestos intoxication 9.8
956 manganese poisoning 9.8
957 machado-joseph disease 9.7
958 b-cell growth factor 9.7
959 colorectal cancer 9.7
960 charcot-marie-tooth disease, demyelinating, type 1a 9.7
961 facial spasm 9.7
962 hair whorl 9.7
963 hypertelorism 9.7
964 hypertriglyceridemia, familial 9.7
965 progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant 1 9.7
966 optic atrophy 1 9.7
967 polykaryocytosis inducer 9.7
968 schistosoma mansoni infection, susceptibility/ 9.7
969 spastic paraplegia 4, autosomal dominant 9.7
970 suppressor of tumorigenicity 3 9.7
971 urate oxidase, pseudogene 9.7
972 vasculitis, lymphocytic, nodular 9.7
973 lipoid congenital adrenal hyperplasia 9.7
974 adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency 9.7
975 alopecia universalis congenita 9.7
976 takayasu arteritis 9.7
977 ataxia-telangiectasia 9.7
978 eosinophilic fasciitis 9.7
979 hutterite cerebroosteonephrodysplasia syndrome 9.7
980 intracranial hypertension, idiopathic 9.7
981 krabbe disease 9.7
982 mycosis fungoides 9.7
983 sudanophilic cerebral sclerosis 9.7
984 sudden infant death syndrome 9.7
985 thymoma, familial 9.7
986 wilson disease 9.7
987 fragile x tremor/ataxia syndrome 9.7
988 tubulin, beta 9.7
989 spastic paraplegia 2, x-linked 9.7
990 astigmatism 9.7
991 reflex sympathetic dystrophy 9.7
992 langerhans cell histiocytosis 9.7
993 anorexia nervosa 9.7
994 mycobacterium tuberculosis 1 9.7
995 phobia, specific 9.7
996 progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant 2 9.7
997 progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant 3 9.7
998 progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant 4 9.7
999 west nile virus 9.7
1000 malaria 9.7
1001 smoking as a quantitative trait locus 3 9.7
1002 gastric cancer 9.7
1003 riboflavin deficiency 9.7
1004 alacrima, achalasia, and mental retardation syndrome 9.7
1005 striatal degeneration, autosomal dominant 2 9.7
1006 hyperlipoproteinemia, type iii 9.7
1007 drug-induced lupus erythematosus 9.7
1008 familial adenomatous polyposis 9.7
1009 usher syndrome 9.7
1010 epidemic typhus 9.7
1011 female breast cancer 9.7
1012 autosomal recessive disease 9.7
1013 rheumatic heart disease 9.7
1014 focal dystonia 9.7
1015 hemorrhagic cystitis 9.7
1016 fragile x-associated tremor/ataxia syndrome 9.7
1017 autosomal recessive cerebellar ataxia 9.7
1018 withdrawal disorder 9.7
1019 brain meningioma 9.7
1020 auditory agnosia 9.7
1021 lymphocytic colitis 9.7
1022 scoliosis 9.7
1023 drug allergy 9.7
1024 hypogonadotropic hypogonadism 9.7
1025 brown's tendon sheath syndrome 9.7
1026 thalassemia 9.7
1027 parotitis 9.7
1028 suppression amblyopia 9.7
1029 amblyopia 9.7
1030 open-angle glaucoma 9.7
1031 lipoid nephrosis 9.7
1032 depersonalization disorder 9.7
1033 spondyloarthropathy 9.7
1034 ornithosis 9.7
1035 pneumocystosis 9.7
1036 mitral valve insufficiency 9.7
1037 cortical blindness 9.7
1038 coronary thrombosis 9.7
1039 lymphocytic choriomeningitis 9.7
1040 paranoid schizophrenia 9.7
1041 vogt-koyanagi-harada disease 9.7
1042 hepatic coma 9.7
1043 acoustic neuroma 9.7
1044 ocular motility disease 9.7
1045 dilated cardiomyopathy 9.7
1046 typhoid fever 9.7
1047 scrub typhus 9.7
1048 tuberous sclerosis 9.7
1049 hyperparathyroidism 9.7
1050 facial neuralgia 9.7
1051 benign paroxysmal positional nystagmus 9.7
1052 schistosomiasis 9.7
1053 algoneurodystrophy 9.7
1054 iritis 9.7
1055 vestibular nystagmus 9.7
1056 azoospermia 9.7
1057 communicating hydrocephalus 9.7
1058 pneumothorax 9.7
1059 retinal vein occlusion 9.7
1060 mitral valve stenosis 9.7
1061 drug-induced hepatitis 9.7
1062 myotonia congenita 9.7
1063 b cell deficiency 9.7
1064 transient cerebral ischemia 9.7
1065 wernicke encephalopathy 9.7
1066 granulomatous angiitis 9.7
1067 benign mesothelioma 9.7
1068 melancholia 9.7
1069 membranoproliferative glomerulonephritis 9.7
1070 testicular cancer 9.7
1071 papillary carcinoma 9.7
1072 acute porphyria 9.7
1073 lysosomal storage disease 9.7
1074 thymoma 9.7
1075 germinoma 9.7
1076 temporal lobe epilepsy 9.7
1077 lateral medullary syndrome 9.7
1078 toxic encephalopathy 9.7
1079 kallmann syndrome 9.7
1080 arthropathy 9.7
1081 craniopharyngioma 9.7
1082 intestinal pseudo-obstruction 9.7
1083 gait apraxia 9.7
1084 milk allergy 9.7
1085 myofibroma 9.7
1086 nominal aphasia 9.7
1087 retrograde amnesia 9.7
1088 ideomotor apraxia 9.7
1089 cavernous hemangioma 9.7
1090 pancreatitis 9.7
1091 subependymal giant cell astrocytoma 9.7
1092 copper deficiency myelopathy 9.7
1093 human immunodeficiency virus infectious disease 9.7
1094 spinal cord ependymoma 9.7
1095 agoraphobia 9.7
1096 bronchitis 9.7
1097 conjunctivitis 9.7
1098 prion disease 9.7
1099 capgras syndrome 9.7
1100 spinal stenosis 9.7
1101 premenstrual tension 9.7
1102 monoclonal gammopathy of uncertain significance 9.7
1103 delusional disorder 9.7
1104 peritonitis 9.7
1105 appendicitis 9.7
1106 osteoarthritis 9.7
1107 cyclothymic disorder 9.7
1108 genital herpes 9.7
1109 in situ carcinoma 9.7
1110 smallpox 9.7
1111 bacterial pneumonia 9.7
1112 mitochondrial encephalomyopathy 9.7
1113 learning disability 9.7
1114 cutaneous leishmaniasis 9.7
1115 erythromelalgia 9.7
1116 homocystinuria 9.7
1117 keratoconjunctivitis 9.7
1118 fasciitis 9.7
1119 refractive error 9.7
1120 peripheral vertigo 9.7
1121 myotonic dystrophy 9.7
1122 bap1 tumor predisposition syndrome 9.7
1123 spastic paraplegia 4 9.7
1124 alien hand syndrome 9.7
1125 autoimmune retinopathy 9.7
1126 chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids 9.7
1127 hyperacusis 9.7
1128 lymphomatoid papulosis 9.7
1129 mercury poisoning 9.7
1130 mollaret meningitis 9.7
1131 paraneoplastic cerebellar degeneration 9.7
1132 post-transplant lymphoproliferative disease 9.7
1133 propriospinal myoclonus 9.7
1134 ring chromosome 5 9.7
1135 spasmodic dysphonia 9.7
1136 superficial siderosis of the central nervous system 9.7
1137 cerebral aneurysms 9.7
1138 deep brain stimulation for movement disorders 9.7
1139 hereditary neuropathies 9.7
1140 subcortical arteriosclerotic encephalopathy 9.7
1141 idiopathic acute transverse myelitis 9.7
1142 perioral myoclonia with absences 9.7
1143 progressive muscular dystrophy 9.7
1144 acute encephalopathy with biphasic seizures and late reduced diffusion 9.7
1145 chronic relapsing inflammatory optic neuropathy 9.7
1146 microcystic stromal tumor 9.7
1147 rubella panencephalitis 9.7
1148 rare disease in surgical orthopedic 9.7
1149 obsolete: laryngeal dyskinesia 9.7
1150 autoinflammatory syndrome 9.7
1151 hyperaldosteronism, familial, type i 9.7
1152 progressive familial heart block, type ia 9.7
1153 chlorpropamide-alcohol flushing 9.7
1154 glioma susceptibility 1 9.7
1155 silver-russell syndrome 9.7
1156 argininosuccinic aciduria 9.7
1157 dihydropyrimidinase deficiency 9.7
1158 fucosidosis 9.7
1159 multiple acyl-coa dehydrogenase deficiency 9.7
1160 sandhoff disease 9.7
1161 canavan disease 9.7
1162 uruguay faciocardiomusculoskeletal syndrome 9.7
1163 barth syndrome 9.7
1164 menkes disease 9.7
1165 gallbladder disease 1 9.7
1166 ventricular fibrillation, paroxysmal familial, 1 9.7
1167 mevalonic aciduria 9.7
1168 alopecia, neurologic defects, and endocrinopathy syndrome 9.7
1169 cholangiocarcinoma 9.7
1170 autoimmune uveitis 9.7
1171 fetal alcohol syndrome 9.7
1172 fetal alcohol spectrum disorder 9.7
1173 paraganglioma 9.7
1174 androgenic alopecia 9.7
1175 pervasive developmental disorder 9.7
1176 cholelithiasis 9.7
1177 cystinosis 9.7
1178 microcytic anemia 9.7
1179 filarial elephantiasis 9.7
1180 familial hypercholesterolemia 9.7
1181 oligospermia 9.7
1182 adult-onset still's disease 9.7
1183 myeloproliferative neoplasm 9.7
1184 severe acute respiratory syndrome 9.7
1185 gastric adenocarcinoma 9.7
1186 coronary stenosis 9.7
1187 clear cell renal cell carcinoma 9.7
1188 hypokalemia 9.7
1189 large cell carcinoma 9.7
1190 intrahepatic cholangiocarcinoma 9.7
1191 hepatoblastoma 9.7
1192 bronchiectasis 9.7
1193 pulmonary emphysema 9.7
1194 neonatal abstinence syndrome 9.7
1195 drug dependence 9.7
1196 cytochrome p450 oxidoreductase deficiency 9.7
1197 bronchopulmonary dysplasia 9.7
1198 heavy metal poisoning 9.7
1199 jamaican vomiting sickness 9.7
1200 nephrogenic systemic fibrosis 9.7
1201 ring chromosome 2 9.7
1202 stenotrophomonas maltophilia infection 9.7
1203 toxic oil syndrome 9.7
1204 acute ackee fruit intoxication 9.7
1205 cocaine intoxication 9.7
1206 spastic ataxia 1, autosomal dominant 9.7
1207 optic atrophy with demyelinating disease of cns 9.7
1208 neurofibroma 9.7
1209 endocrine gland cancer 9.7 MIR96 MIR223 MIR20A MIR17 MIR145 MIR142
1210 endocrine system disease 9.7 MIR96 MIR223 MIR20A MIR17 MIR145 MIR142
1211 angelman syndrome 9.6
1212 alopecia, androgenetic, 1 9.6
1213 gastroesophageal reflux 9.6
1214 floating-harbor syndrome 9.6
1215 legg-calve-perthes disease 9.6
1216 proline-negative auxotroph of hamster, complementation of 9.6
1217 scoliosis, isolated 1 9.6
1218 acyl-coa dehydrogenase, very long-chain, deficiency of 9.6
1219 alkaptonuria 9.6
1220 argininemia 9.6
1221 aspartylglucosaminuria 9.6
1222 citrullinemia, classic 9.6
1223 cystinuria 9.6
1224 fructose intolerance, hereditary 9.6
1225 fructose-1,6-bisphosphatase deficiency 9.6
1226 homocystinuria due to deficiency of n -methylenetetrahydrofolate reductase activity 9.6
1227 carbamoyl phosphate synthetase i deficiency, hyperammonemia due to 9.6
1228 mucopolysaccharidosis, type iiia 9.6
1229 neuraminidase deficiency 9.6
1230 hyper-igd syndrome 9.6
1231 polycythemia vera 9.6
1232 refsum disease, classic 9.6
1233 infantile sialic acid storage disease 9.6
1234 spermatogenic failure 4 9.6
1235 sulfite oxidase deficiency, isolated 9.6
1236 fragile x syndrome 9.6
1237 agammaglobulinemia, x-linked 9.6
1238 mend syndrome 9.6
1239 ichthyosis, x-linked 9.6
1240 convulsions, familial infantile, with paroxysmal choreoathetosis 9.6
1241 hemophagocytic lymphohistiocytosis, familial, 2 9.6
1242 salla disease 9.6
1243 transaldolase deficiency 9.6
1244 ehlers-danlos syndrome, classic-like 9.6
1245 scheie syndrome 9.6
1246 epilepsy, partial, with pericentral spikes 9.6
1247 patent ductus arteriosus 1 9.6
1248 legionnaire disease 9.6
1249 aromatic l-amino acid decarboxylase deficiency 9.6
1250 cavitary optic disc anomalies 9.6
1251 neurodegeneration due to cerebral folate transport deficiency 9.6
1252 hypotrichosis and recurrent skin vesicles 9.6
1253 alpha-1-antitrypsin deficiency 9.6
1254 hypertelorism, preauricular sinus, punctal pits, and deafness 9.6
1255 pulmonary hypertension, primary, 3 9.6
1256 pulmonary hypertension, primary, 4 9.6
1257 bainbridge-ropers syndrome 9.6
1258 mulchandani-bhoj-conlin syndrome 9.6
1259 chronic ulcer of skin 9.6
1260 angiosarcoma 9.6
1261 superficial mycosis 9.6
1262 otomycosis 9.6
1263 fusariosis 9.6
1264 congenital hypothyroidism 9.6
1265 hypermethioninemia 9.6
1266 extrapulmonary tuberculosis 9.6
1267 early infantile epileptic encephalopathy 9.6
1268 lymphoplasmacytic lymphoma 9.6
1269 peripheral t-cell lymphoma 9.6
1270 limb ischemia 9.6
1271 renal fibrosis 9.6
1272 ovarian clear cell carcinoma 9.6
1273 cardiac arrest 9.6
1274 transient neonatal diabetes mellitus 9.6
1275 3-methylglutaconic aciduria 9.6
1276 glucocorticoid-induced osteoporosis 9.6
1277 muscular disease 9.6
1278 childhood acute lymphocytic leukemia 9.6
1279 igg4-related disease 9.6
1280 multicentric castleman disease 9.6
1281 castleman disease 9.6
1282 pelvic inflammatory disease 9.6
1283 corneal disease 9.6
1284 keratoconus 9.6
1285 left bundle branch hemiblock 9.6
1286 osteomalacia 9.6
1287 fanconi syndrome 9.6
1288 hand, foot and mouth disease 9.6
1289 vitamin k deficiency bleeding 9.6
1290 hemopericardium 9.6
1291 onchocerciasis 9.6
1292 neonatal diabetes mellitus 9.6
1293 pericardial effusion 9.6
1294 conn's syndrome 9.6
1295 otosclerosis 9.6
1296 mucopolysaccharidosis iii 9.6
1297 plasmodium vivax malaria 9.6
1298 campylobacteriosis 9.6
1299 hereditary angioedema 9.6
1300 aggressive periodontitis 9.6
1301 dermatomycosis 9.6
1302 keratosis 9.6
1303 neuroendocrine tumor 9.6
1304 peritoneal mesothelioma 9.6
1305 trichomoniasis 9.6
1306 coccidiosis 9.6
1307 leptospirosis 9.6
1308 liver angiosarcoma 9.6
1309 laryngeal squamous cell carcinoma 9.6
1310 cervix carcinoma 9.6
1311 carbohydrate metabolic disorder 9.6
1312 gm2 gangliosidosis 9.6
1313 glycoproteinosis 9.6
1314 systemic mastocytosis 9.6
1315 mastocytosis 9.6
1316 lung squamous cell carcinoma 9.6
1317 adrenal carcinoma 9.6
1318 ureteral obstruction 9.6
1319 overnutrition 9.6
1320 malignant pleural mesothelioma 9.6
1321 polycythemia 9.6
1322 intestinal obstruction 9.6
1323 myeloid sarcoma 9.6
1324 seborrheic dermatitis 9.6
1325 actinic keratosis 9.6
1326 skin melanoma 9.6
1327 status asthmaticus 9.6
1328 tracheitis 9.6
1329 babesiosis 9.6
1330 bacterial conjunctivitis 9.6
1331 cocaine dependence 9.6
1332 hyperphenylalaninemia 9.6
1333 classic galactosemia and clinical variant galactosemia 9.6
1334 dystrophinopathies 9.6
1335 al amyloidosis 9.6
1336 bowen's disease 9.6
1337 complete androgen insensitivity syndrome 9.6
1338 dihydroxyadeninuria 9.6
1339 dwarfism 9.6
1340 mycobacterium fortuitum 9.6
1341 mycobacterium gordonae 9.6
1342 ocular toxoplasmosis 9.6
1343 ornithinemia 9.6
1344 refsum disease, infantile form 9.6
1345 sutton disease 2 9.6
1346 thiopurine s methyltranferase deficiency 9.6
1347 aldosterone-producing adenoma 9.6
1348 familial hyperaldosteronism 9.6
1349 idiopathic infantile hypercalcemia 9.6
1350 immune hydrops fetalis 9.6
1351 acute radiation syndrome 9.6
1352 folinic acid-responsive seizures 9.6
1353 primary progressive freezing gait 9.6
1354 lysosomal disease 9.6
1355 neurofibromatosis, type ii 9.6
1356 aniridia 1 9.6
1357 annular erythema 9.6
1358 episodic ataxia, type 2 9.6
1359 leukemia, chronic lymphocytic 2 9.6
1360 bladder diverticulum 9.6
1361 cardiomyopathy, familial hypertrophic, 2 9.6
1362 hypercarotenemia and vitamin a deficiency, autosomal dominant 9.6
1363 clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly 9.6
1364 coproporphyria, hereditary 9.6
1365 craniometaphyseal dysplasia, autosomal dominant 9.6
1366 optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy 9.6
1367 diabetes mellitus, noninsulin-dependent 9.6
1368 duane retraction syndrome 1 9.6
1369 dementia, lewy body 9.6
1370 multiple endocrine neoplasia, type i 9.6
1371 erythroleukemia, familial 9.6
1372 factor viii deficiency 9.6
1373 fibrosis of extraocular muscles, congenital, 1 9.6
1374 immunoglobulin a deficiency 1 9.6
1375 gerstmann-straussler disease 9.6
1376 gilles de la tourette syndrome 9.6
1377 periodic fever, familial, autosomal dominant 9.6
1378 hypercalciuria, absorptive, 2 9.6
1379 endosteal hyperostosis, autosomal dominant 9.6
1380 ichthyosis hystrix, curth-macklin type 9.6
1381 intussusception 9.6
1382 keratitis, hereditary 9.6
1383 kleine-levin hibernation syndrome 9.6
1384 leiomyoma, uterine 9.6
1385 leukemia, acute monocytic 9.6
1386 lichen sclerosus et atrophicus 9.6
1387 marfan syndrome 9.6
1388 thyroid carcinoma, familial medullary 9.6
1389 medulloblastoma 9.6
1390 melkersson-rosenthal syndrome 9.6
1391 meniere disease 9.6
1392 facioscapulohumeral muscular dystrophy 1 9.6
1393 neutrophil migration 9.6
1394 multicentric carpotarsal osteolysis syndrome 9.6
1395 otitis media 9.6
1396 paramyotonia congenita of von eulenburg 9.6
1397 benign chronic pemphigus 9.6
1398 pemphigus vulgaris, familial 9.6
1399 pheochromocytoma 9.6
1400 pneumothorax, primary spontaneous 9.6
1401 peutz-jeghers syndrome 9.6
1402 porphyria cutanea tarda, type i 9.6
1403 porphyria cutanea tarda 9.6
1404 rubinstein-taybi syndrome 1 9.6
1405 small cell cancer of the lung 9.6
1406 spinocerebellar ataxia 2 9.6
1407 temporal arteritis 9.6
1408 tetralogy of fallot 9.6
1409 digeorge syndrome 9.6
1410 down syndrome 9.6
1411 tuberous sclerosis 1 9.6
1412 muckle-wells syndrome 9.6
1413 varicose veins 9.6
1414 vasculopathy, retinal, with cerebral leukodystrophy 9.6
1415 von hippel-lindau syndrome 9.6
1416 williams-beuren syndrome 9.6
1417 chiari malformation type ii 9.6
1418 premature centromere division 9.6
1419 cryptorchidism, unilateral or bilateral 9.6
1420 cystic fibrosis 9.6
1421 polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1 9.6
1422 disseminated sclerosis with narcolepsy 9.6
1423 enterocolitis 9.6
1424 gaucher disease, type i 9.6
1425 glycogen storage disease ii 9.6
1426 goodpasture syndrome 9.6
1427 hydrocephalus, congenital, 1 9.6
1428 hydrocephalus due to congenital stenosis of aqueduct of sylvius 9.6
1429 hypoadrenocorticism, familial 9.6
1430 hypogonadism, male 9.6
1431 lambert syndrome 9.6
1432 leprosy 3 9.6
1433 multiple pterygium syndrome, lethal type 9.6
1434 epilepsy, myoclonic juvenile 9.6
1435 myxedema 9.6
1436 niemann-pick disease, type c1 9.6
1437 progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive 1 9.6
1438 nonarteritic anterior ischemic optic neuropathy 9.6
1439 papilloma of choroid plexus 9.6
1440 periodontitis, chronic 9.6
1441 intrinsic factor deficiency 9.6
1442 pierre robin syndrome 9.6
1443 inflammatory bowel disease 1 9.6
1444 hemophagocytic lymphohistiocytosis, familial, 1 9.6
1445 retinitis pigmentosa 9.6
1446 spastic ataxia, charlevoix-saguenay type 9.6
1447 spastic paraplegia 15, autosomal recessive 9.6
1448 spastic pseudosclerosis 9.6
1449 asplenia, isolated congenital 9.6
1450 tardive dyskinesia 9.6
1451 wernicke-korsakoff syndrome 9.6
1452 wiskott-aldrich syndrome 9.6
1453 arts syndrome 9.6
1454 immunodysregulation, polyendocrinopathy, and enteropathy, x-linked 9.6
1455 hemophilia a 9.6
1456 muscular dystrophy, duchenne type 9.6
1457 paine syndrome 9.6
1458 androgen insensitivity, partial 9.6
1459 reticuloendotheliosis, x-linked 9.6
1460 rett syndrome 9.6
1461 parkinson disease 2, autosomal recessive juvenile 9.6
1462 retinitis pigmentosa 11 9.6
1463 pituitary adenoma, prolactin-secreting 9.6
1464 budd-chiari syndrome 9.6
1465 charcot-marie-tooth disease, demyelinating, type 1c 9.6
1466 supranuclear palsy, progressive, 1 9.6
1467 microphthalmia, syndromic 8 9.6
1468 systemic lupus erythematosus 1 9.6
1469 alzheimer disease 5 9.6
1470 cholestasis, progressive familial intrahepatic, 3 9.6
1471 macular degeneration, age-related, 1 9.6
1472 dermatitis, atopic 9.6
1473 sickle cell anemia 9.6
1474 cervical cancer 9.6
1475 megalencephalic leukoencephalopathy with subcortical cysts 1 9.6
1476 chudley-mccullough syndrome 9.6
1477 mitochondrial complex v deficiency, nuclear type 1 9.6
1478 inflammatory bowel disease 3 9.6
1479 huntington disease-like 3 9.6
1480 psoriasis 6 9.6
1481 paragangliomas 3 9.6
1482 schizophrenia 10 9.6
1483 inflammatory bowel disease 5 9.6
1484 huntington disease-like 2 9.6
1485 longevity 2 9.6
1486 amyotrophic lateral sclerosis 3 9.6
1487 lymphangioleiomyomatosis 9.6
1488 gastrointestinal stromal tumor 9.6
1489 creatinine clearance quantitative trait locus 9.6
1490 spastic paraplegia 7, autosomal recessive 9.6
1491 endometrial cancer 9.6
1492 respiratory rhythmicity in sleep 9.6
1493 aplastic anemia 9.6
1494 alzheimer disease 10 9.6
1495 chromosome 16p13.3 deletion syndrome, proximal 9.6
1496 leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation 9.6
1497 charcot-marie-tooth disease, type 4j 9.6
1498 legius syndrome 9.6
1499 primary lateral sclerosis, adult, 1 9.6
1500 spastic paraplegia 39, autosomal recessive 9.6
1501 diabetes mellitus, ketosis-prone 9.6
1502 lung cancer susceptibility 3 9.6
1503 microvascular complications of diabetes 3 9.6
1504 microvascular complications of diabetes 4 9.6
1505 microvascular complications of diabetes 6 9.6
1506 microvascular complications of diabetes 7 9.6
1507 synesthesia 9.6
1508 hearing loss, noise-induced 9.6
1509 bile acid malabsorption, primary 9.6
1510 ectodermal dysplasia-syndactyly syndrome 1 9.6
1511 ectodermal dysplasia-syndactyly syndrome 2 9.6
1512 complement component 3 deficiency, autosomal recessive 9.6
1513 hirschsprung disease, cardiac defects, and autonomic dysfunction 9.6
1514 beta-thalassemia 9.6
1515 delayed sleep phase disorder 9.6
1516 glutathione peroxidase deficiency 9.6
1517 barrett esophagus 9.6
1518 pulmonary fibrosis and/or bone marrow failure, telomere-related, 2 9.6
1519 palmoplantar carcinoma, multiple self-healing 9.6
1520 epileptic encephalopathy, childhood-onset 9.6
1521 retinal dystrophy with or without macular staphyloma 9.6
1522 helix syndrome 9.6
1523 alkuraya-kucinskas syndrome 9.6
1524 fetal akinesia deformation sequence 2 9.6
1525 nephrotic syndrome, type 21 9.6
1526 autoimmune peripheral neuropathy 9.6
1527 erythema multiforme 9.6
1528 epstein-barr virus hepatitis 9.6
1529 lambert-eaton myasthenic syndrome 9.6
1530 hypophosphatemia 9.6
1531 brugada syndrome 9.6
1532 hyperphosphatemia 9.6
1533 multinodular goiter 9.6
1534 exanthema subitum 9.6
1535 variola major 9.6
1536 paralytic poliomyelitis 9.6
1537 congenital generalized lipodystrophy 9.6
1538 distal arthrogryposis 9.6
1539 spastic cerebral palsy 9.6
1540 chorioamnionitis 9.6
1541 3-methylcrotonyl-coa carboxylase deficiency 9.6
1542 congenital intrinsic factor deficiency 9.6
1543 anaplastic large cell lymphoma 9.6
1544 third-degree atrioventricular block 9.6
1545 peripheral artery disease 9.6
1546 segmental dystonia 9.6
1547 anismus 9.6
1548 oculogyric crisis 9.6
1549 follicular lymphoma 9.6
1550 adrenal cortical adenoma 9.6
1551 adrenal gland pheochromocytoma 9.6
1552 hereditary ataxia 9.6
1553 infective endocarditis 9.6
1554 autism spectrum disorder 9.6
1555 paraphilia disorder 9.6
1556 apperceptive agnosia 9.6
1557 finger agnosia 9.6
1558 form agnosia 9.6
1559 ischemic colitis 9.6
1560 basal ganglia calcification 9.6
1561 stuttering 9.6
1562 inguinal hernia 9.6
1563 breast abscess 9.6
1564 myelomeningocele 9.6
1565 zika fever 9.6
1566 pollen allergy 9.6
1567 autosomal recessive congenital ichthyosis 9.6
1568 hyperekplexia 9.6
1569 early-onset parkinson's disease 9.6
1570 progressive familial intrahepatic cholestasis 9.6
1571 intrahepatic cholestasis of pregnancy 9.6
1572 myoglobinuria 9.6
1573 hepatic veno-occlusive disease 9.6
1574 mucositis 9.6
1575 polycystic kidney disease 9.6
1576 desmoid tumor 9.6
1577 non-alcoholic steatohepatitis 9.6
1578 cortisone reductase deficiency 9.6
1579 tabes dorsalis 9.6
1580 cycloplegia 9.6
1581 cerebral artery occlusion 9.6
1582 sialadenitis 9.6
1583 chronic meningitis 9.6
1584 hypopyon 9.6
1585 glucose intolerance 9.6
1586 tropical sprue 9.6
1587 renal hypertension 9.6
1588 portal hypertension 9.6
1589 gastric ulcer 9.6
1590 malignant hypertension 9.6
1591 murray valley encephalitis 9.6
1592 partial third-nerve palsy 9.6
1593 microcephaly 9.6
1594 intracranial aneurysm 9.6
1595 spastic diplegia 9.6
1596 spastic quadriplegia 9.6
1597 asphyxia neonatorum 9.6
1598 prostatic hypertrophy 9.6
1599 anhidrosis 9.6
1600 disseminated intravascular coagulation 9.6
1601 keratomalacia 9.6
1602 megacolon 9.6
1603 alternating exotropia 9.6
1604 exotropia 9.6
1605 autonomic neuropathy 9.6
1606 oculomotor nerve paralysis 9.6
1607 cauda equina syndrome 9.6
1608 hyperandrogenism 9.6
1609 presbyopia 9.6
1610 clubfoot 9.6
1611 coronary artery anomaly 9.6
1612 mononeuropathy 9.6
1613 ischemic neuropathy 9.6
1614 esophagitis 9.6
1615 pica disease 9.6
1616 radial nerve lesion 9.6
1617 radial neuropathy 9.6
1618 common variable immunodeficiency 9.6
1619 dengue disease 9.6
1620 male infertility 9.6
1621 fetishism 9.6
1622 spinal muscular atrophy 9.6
1623 complex partial epilepsy 9.6
1624 pathological gambling 9.6
1625 secondary hyperparathyroidism 9.6
1626 dyscalculia 9.6
1627 paracoccidioidomycosis 9.6
1628 vestibular neuronitis 9.6
1629 hypochondriasis 9.6
1630 vertebrobasilar insufficiency 9.6
1631 relapsing fever 9.6
1632 branch retinal artery occlusion 9.6
1633 vertebral artery insufficiency 9.6
1634 central retinal artery occlusion 9.6
1635 severe pre-eclampsia 9.6
1636 klebsiella pneumonia 9.6
1637 pedophilia 9.6
1638 megaloblastic anemia 9.6
1639 skin sarcoidosis 9.6
1640 hepatic encephalopathy 9.6
1641 scleritis 9.6
1642 osteopetrosis 9.6
1643 cholestasis 9.6
1644 beriberi 9.6
1645 achromatopsia 9.6
1646 somatization disorder 9.6
1647 bladder neck obstruction 9.6
1648 rubeosis iridis 9.6
1649 poems syndrome 9.6
1650 autoimmune polyendocrine syndrome 9.6
1651 alcoholic neuropathy 9.6
1652 oral candidiasis 9.6
1653 mixed malaria 9.6
1654 capillary leak syndrome 9.6
1655 niemann-pick disease 9.6
1656 foster-kennedy syndrome 9.6
1657 papilledema 9.6
1658 centronuclear myopathy 9.6
1659 olivopontocerebellar atrophy 9.6
1660 gingival disease 9.6
1661 cholera 9.6
1662 candidiasis 9.6
1663 arthus reaction 9.6
1664 angioedema 9.6
1665 lymphadenitis 9.6
1666 hypoglycemic coma 9.6
1667 ventricular septal defect 9.6
1668 chronic cystitis 9.6
1669 heart septal defect 9.6
1670 neovascular glaucoma 9.6
1671 ichthyosis 9.6
1672 duodenal ulcer 9.6
1673 histoplasmosis 9.6
1674 cryptosporidiosis 9.6
1675 squamous cell carcinoma 9.6
1676 factitious disorder 9.6
1677 thyroid gland cancer 9.6
1678 neuroendocrine carcinoma 9.6
1679 calcinosis 9.6
1680 gaucher's disease 9.6
1681 hypothalamic disease 9.6
1682 cholecystitis 9.6
1683 exostosis 9.6
1684 encephalomalacia 9.6
1685 hyperostosis 9.6
1686 brain germinoma 9.6
1687 brain sarcoma 9.6
1688 vaginitis 9.6
1689 essential thrombocythemia 9.6
1690 thrombocytosis 9.6
1691 basilar artery insufficiency 9.6
1692 pharyngitis 9.6
1693 keratopathy 9.6
1694 nocardiosis 9.6
1695 monoclonal paraproteinemia 9.6
1696 macrocytic anemia 9.6
1697 gangliocytoma 9.6
1698 glomus tumor 9.6
1699 acromegaly 9.6
1700 chronic inflammatory demyelinating polyneuritis 9.6
1701 kidney cancer 9.6
1702 synovitis 9.6
1703 sick building syndrome 9.6
1704 contact dermatitis 9.6
1705 immune system disease 9.6
1706 cryoglobulinemia 9.6
1707 pulmonary tuberculosis 9.6
1708 germ cell cancer 9.6
1709 early myoclonic encephalopathy 9.6
1710 cystic lymphangioma 9.6
1711 gingival overgrowth 9.6
1712 teratoma 9.6
1713 angiomyolipoma 9.6
1714 gm1 gangliosidosis 9.6
1715 histrionic personality disorder 9.6
1716 fibrosarcoma 9.6
1717 liposarcoma 9.6
1718 cerebritis 9.6
1719 plague 9.6
1720 cellulitis 9.6
1721 mixed connective tissue disease 9.6
1722 chronic wasting disease 9.6
1723 superior mesenteric artery syndrome 9.6
1724 acute retinal necrosis syndrome 9.6
1725 bladder disease 9.6
1726 intermittent claudication 9.6
1727 plasmacytoma 9.6
1728 placental insufficiency 9.6
1729 thyroid gland medullary carcinoma 9.6
1730 eosinophilic gastroenteritis 9.6
1731 heart valve disease 9.6
1732 blood group incompatibility 9.6
1733 echolalia 9.6
1734 intracranial thrombosis 9.6
1735 hyperglycemia 9.6
1736 hypertrichosis 9.6
1737 brain stem glioma 9.6
1738 akinetic mutism 9.6
1739 erdheim-chester disease 9.6
1740 non-langerhans-cell histiocytosis 9.6
1741 intracranial embolism 9.6
1742 hepatitis e 9.6
1743 central nervous system germinoma 9.6
1744 seminoma 9.6
1745 multiple chemical sensitivity 9.6
1746 uremia 9.6
1747 intracranial hypotension 9.6
1748 somatoform disorder 9.6
1749 immune-complex glomerulonephritis 9.6
1750 ganglioneuroma 9.6
1751 sebaceous adenocarcinoma 9.6
1752 rhabdoid meningioma 9.6
1753 mixed glioma 9.6
1754 ganglioglioma 9.6
1755 urinary tract obstruction 9.6
1756 chronic polyneuropathy 9.6
1757 von economo's disease 9.6
1758 hemangioblastoma 9.6
1759 anterograde amnesia 9.6
1760 third cranial nerve disease 9.6
1761 retinal disease 9.6
1762 inferior myocardial infarction 9.6
1763 eosinophilic pneumonia 9.6
1764 microglandular adenosis 9.6
1765 gliomatosis cerebri 9.6
1766 mitochondrial myopathy 9.6
1767 protoplasmic astrocytoma 9.6
1768 meningothelial meningioma 9.6
1769 childhood leukemia 9.6
1770 carotid artery occlusion 9.6
1771 osteochondrosis 9.6
1772 septic arthritis 9.6
1773 scabies 9.6
1774 complement component 3 deficiency 9.6
1775 kidney angiomyolipoma 9.6
1776 localized scleroderma 9.6
1777 retinal artery occlusion 9.6
1778 subcorneal pustular dermatosis 9.6
1779 monocytic leukemia 9.6
1780 scarlet fever 9.6
1781 eating disorder 9.6
1782 perinatal necrotizing enterocolitis 9.6
1783 molluscum contagiosum 9.6
1784 autosomal dominant polycystic kidney disease 9.6
1785 macroglobulinemia 9.6
1786 peliosis hepatis 9.6
1787 visceral leishmaniasis 9.6
1788 lichen planus 9.6
1789 urea cycle disorder 9.6
1790 cleft lip 9.6
1791 urethral diverticulum 9.6
1792 hypopituitarism 9.6
1793 acute myocardial infarction 9.6
1794 allergic asthma 9.6
1795 postpartum depression 9.6
1796 episodic ataxia 9.6
1797 congenital nystagmus 9.6
1798 aphthous stomatitis 9.6
1799 myocardial stunning 9.6
1800 hypotropia 9.6
1801 hypervitaminosis d 9.6
1802 hemophilia 9.6
1803 limb-girdle muscular dystrophy 9.6
1804 csf1r-related adult-onset leukoencephalopathy with axonal spheroids and pigmented glia 9.6
1805 genetic prion diseases 9.6
1806 hypertrophic cardiomyopathy 9.6
1807 syne1 deficiency 9.6
1808 sickle cell disease 9.6
1809 spastic paraplegia 11 9.6
1810 acquired hemophilia a 9.6
1811 acute graft versus host disease 9.6
1812 acute monoblastic leukemia 9.6
1813 acute mountain sickness 9.6
1814 acute posterior multifocal placoid pigment epitheliopathy 9.6
1815 acute zonal occult outer retinopathy 9.6
1816 adenosylcobalamin deficiency 9.6
1817 alopecia totalis 9.6
1818 aminoaciduria 9.6
1819 anaplastic oligoastrocytoma 9.6
1820 anaplastic oligodendroglioma 9.6
1821 antisynthetase syndrome 9.6
1822 athetosis 9.6
1823 candida glabrata 9.6
1824 carcinoid syndrome 9.6
1825 chromosomal triplication 9.6
1826 cluttering 9.6
1827 congenital extrahepatic portosystemic shunt 9.6
1828 congenital hydrocephalus 9.6
1829 cytomegalic inclusion disease 9.6
1830 diencephalic syndrome 9.6
1831 drug reaction with eosinophilia and systemic symptoms 9.6
1832 fasting hypoglycemia 9.6
1833 foix chavany marie syndrome 9.6
1834 gangliosidosis 9.6
1835 growth hormone deficiency 9.6
1836 hansen's disease 9.6
1837 hashimoto encephalopathy 9.6
1838 hemorrhagic proctocolitis 9.6
1839 heparin-induced thrombocytopenia 9.6
1840 herpes zoster ophthalmicus 9.6
1841 hip subluxation 9.6
1842 homologous wasting disease 9.6
1843 hypertrophic olivary degeneration 9.6
1844 hypocomplementemic urticarial vasculitis 9.6
1845 idiopathic edema 9.6
1846 idiopathic neutropenia 9.6
1847 idiopathic spinal cord herniation 9.6
1848 leukoplakia 9.6
1849 lymphocytic hypophysitis 9.6
1850 lymphoma aids related 9.6
1851 lymphomatous thyroiditis 9.6
1852 lymphosarcoma 9.6
1853 macrophage activation syndrome 9.6
1854 mycobacterium kansasii 9.6
1855 necrotizing autoimmune myopathy 9.6
1856 nodular regenerative hyperplasia 9.6
1857 nondystrophic myotonia 9.6
1858 oral leukoplakia 9.6
1859 pediatric acute-onset neuropsychiatric syndrome 9.6
1860 pontine hemorrhage 9.6
1861 precocious puberty 9.6
1862 progressive encephalomyelitis with rigidity and myoclonus 9.6
1863 pulmonary hyalinizing granuloma 9.6
1864 pustular psoriasis 9.6
1865 pyogenic granuloma 9.6
1866 recurrent peripheral facial palsy 9.6
1867 rheumatoid factor-negative juvenile idiopathic arthritis 9.6
1868 scleromyxedema 9.6
1869 spastic paraplegia 10 9.6
1870 spastic paraplegia 15 9.6
1871 spastic paraplegia 39 9.6
1872 spinal shock 9.6
1873 splenomegaly 9.6
1874 stevens-johnson syndrome/toxic epidermal necrolysis 9.6
1875 streptococcal group a invasive disease 9.6
1876 thunderclap headache 9.6
1877 wells syndrome 9.6
1878 age-related hearing loss 9.6
1879 central precocious puberty 9.6
1880 isolated pierre robin sequence 9.6
1881 multiple endocrine neoplasia 9.6
1882 angiomatosis 9.6
1883 cavernous malformation 9.6
1884 cerebral beriberi 9.6
1885 cerebral hypoxia 9.6
1886 extrapontine myelinolysis 9.6
1887 hydromyelia 9.6
1888 paroxysmal choreoathetosis 9.6
1889 persistent vegetative state 9.6
1890 pituitary tumors 9.6
1891 postherpetic neuralgia 9.6
1892 spinal cord infarction 9.6
1893 thomsen's myotonia 9.6
1894 b-cell non-hodgkin lymphoma 9.6
1895 cleft lip/palate 9.6
1896 trigeminal autonomic cephalalgia 9.6
1897 high-grade astrocytoma 9.6
1898 autosomal recessive spastic ataxia 9.6
1899 lmna-related cardiocutaneous progeria syndrome 9.6
1900 familial intrahepatic cholestasis 9.6
1901 disorder of copper metabolism 9.6
1902 rare paroxysmal movement disorder 9.6
1903 aggressive b-cell non-hodgkin lymphoma 9.6
1904 spontaneous intracranial hypotension 9.6
1905 mitochondrial neurogastrointestinal encephalomyopathy 9.6
1906 secondary vasculitis 9.6
1907 obsolete: small pox 9.6
1908 erythema multiforme major 9.6
1909 methanol poisoning 9.6
1910 congenital amyoplasia 9.6
1911 obsolete: squamous cell carcinoma of head and neck 9.6
1912 igg4-related thyroid disease 9.6
1913 pneumococcal meningitis 9.6
1914 bickerstaff brainstem encephalitis 9.6
1915 focal myositis 9.6
1916 serotonin syndrome 9.6
1917 diffuse alveolar hemorrhage 9.6
1918 radiation myelitis 9.6
1919 secondary erythromelalgia 9.6
1920 premature aging 9.6
1921 x-linked intellectual disability-macrocephaly-macroorchidism syndrome 9.6
1922 large granular lymphocyte leukemia 9.6
1923 rare tumor 9.6
1924 coronary ostial stenosis or atresia 9.6
1925 acute myeloid leukemia with 11q23 abnormalities 9.6
1926 acute motor axonal neuropathy 9.6
1927 accessory mitral valve tissue 9.6
1928 undetermined colitis 9.6
1929 precursor t-cell acute lymphoblastic leukemia 9.6
1930 secondary syringomyelia 9.6
1931 achondroplasia 9.5
1932 alzheimer disease 2 9.5
1933 aortic valve disease 1 9.5
1934 exudative vitreoretinopathy 1 9.5
1935 fucosidase regulator 9.5
1936 glaucoma, primary open angle 9.5
1937 diaphragmatic hernia, congenital 9.5
1938 immunoglobulin e concentration, serum 9.5
1939 cholestasis, intrahepatic, of pregnancy, 1 9.5
1940 lymphatic malformation 5 9.5
1941 melanoma, uveal 9.5
1942 mesothelioma, malignant 9.5
1943 antigen defined by monoclonal antibody aj9 9.5
1944 antigen defined by monoclonal antibody t87 9.5
1945 nondisjunction 9.5
1946 hyperuricemic nephropathy, familial juvenile, 1 9.5
1947 amyotrophy, hereditary neuralgic 9.5
1948 pectus excavatum 9.5
1949 polydactyly, preaxial i 9.5
1950 prader-willi syndrome 9.5
1951 cardiomyopathy, familial hypertrophic, 1 9.5
1952 alpha-methylacetoacetic aciduria 9.5
1953 iron-refractory iron deficiency anemia 9.5
1954 cystathioninuria 9.5
1955 d-glyceric aciduria 9.5
1956 schopf-schulz-passarge syndrome 9.5
1957 friedreich ataxia 9.5
1958 galactokinase deficiency 9.5
1959 gapo syndrome 9.5
1960 glycogen storage disease ia 9.5
1961 glycogen storage disease iii 9.5
1962 l-2-hydroxyglutaric aciduria 9.5
1963 3-hydroxy-3-methylglutaryl-coa lyase deficiency 9.5
1964 methane production 9.5
1965 myopathy, myosin storage, autosomal recessive 9.5
1966 persistent mullerian duct syndrome, types i and ii 9.5
1967 polycystic kidney disease 4 with or without polycystic liver disease 9.5
1968 short stature-obesity syndrome 9.5
1969 tay-sachs disease 9.5
1970 alport syndrome 1, x-linked 9.5
1971 adenomyosis 9.5
1972 suppression of tumorigenicity 12 9.5
1973 osteoporosis and oculocutaneous hypopigmentation syndrome 9.5
1974 trimethylaminuria 9.5
1975 medullary cystic kidney disease 2 9.5
1976 progressive familial heart block, type ib 9.5
1977 nephrolithiasis, uric acid 9.5
1978 maturity-onset diabetes of the young 9.5
1979 spermatogenic failure 3 9.5
1980 niemann-pick disease, type b 9.5
1981 myopathy, myosin storage, autosomal dominant 9.5
1982 asthma-related traits 2 9.5
1983 leukoencephalopathy, arthritis, colitis, and hypogammaglobulinema 9.5
1984 salt and pepper developmental regression syndrome 9.5
1985 preterm premature rupture of the membranes 9.5
1986 hamamy syndrome 9.5
1987 kawasaki disease 9.5
1988 congenital disorder of glycosylation, type in 9.5
1989 breast-ovarian cancer, familial 2 9.5
1990 parkinsonism-dystonia, infantile, 1 9.5
1991 beta-ureidopropionase deficiency 9.5
1992 microcephaly, epilepsy, and diabetes syndrome 9.5
1993 mannose-binding lectin deficiency 9.5
1994 ras-associated autoimmune leukoproliferative disorder 9.5
1995 cerebellar ataxia, neuropathy, and vestibular areflexia syndrome 9.5
1996 retinal dystrophy, iris coloboma, and comedogenic acne syndrome 9.5
1997 nephrotic syndrome, type 8 9.5
1998 hypobetalipoproteinemia, familial, 1 9.5
1999 chops syndrome 9.5
2000 west syndrome 9.5
2001 kashin-beck disease 9.5
2002 streptococcus pneumonia 9.5
2003 2-hydroxyglutaric aciduria 9.5
2004 alcohol-related birth defect 9.5
2005 polycystic liver disease 9.5
2006 persistent mullerian duct syndrome 9.5
2007 endometrial hyperplasia 9.5
2008 sitosterolemia 9.5
2009 thymus lymphoma 9.5
2010 amyotrophic neuralgia 9.5
2011 microinvasive gastric cancer 9.5
2012 short bowel syndrome 9.5
2013 interstitial nephritis 9.5
2014 giardiasis 9.5
2015 chronic pyelonephritis 9.5
2016 japanese encephalitis 9.5
2017 borderline personality disorder 9.5
2018 obsessive-compulsive personality disorder 9.5
2019 ovarian disease 9.5
2020 myiasis 9.5
2021 spotted fever 9.5
2022 appendix cancer 9.5
2023 cat-scratch disease 9.5
2024 endometriosis of ovary 9.5
2025 hypertensive heart disease 9.5
2026 choledocholithiasis 9.5
2027 hepatorenal syndrome 9.5
2028 dengue hemorrhagic fever 9.5
2029 nephronophthisis 9.5
2030 tick-borne relapsing fever 9.5
2031 paronychia 9.5
2032 hellp syndrome 9.5
2033 right bundle branch block 9.5
2034 mycoplasma pneumoniae pneumonia 9.5
2035 glanders 9.5
2036 sapho syndrome 9.5
2037 interstitial cystitis 9.5
2038 blackwater fever 9.5
2039 boutonneuse fever 9.5
2040 pleuropneumonia 9.5
2041 sclerosing keratitis 9.5
2042 gonadal dysgenesis 9.5
2043 sporotrichosis 9.5
2044 glossitis 9.5
2045 prostatitis 9.5
2046 leiomyosarcoma 9.5
2047 giant cell tumor 9.5
2048 intestinal perforation 9.5
2049 vulvovaginal candidiasis 9.5
2050 neonatal jaundice 9.5
2051 transitional cell carcinoma 9.5
2052 myoma 9.5
2053 glycogen storage disease 9.5
2054 idiopathic interstitial pneumonia 9.5
2055 acalculous cholecystitis 9.5
2056 glucosephosphate dehydrogenase deficiency 9.5
2057 cystic kidney disease 9.5
2058 primary hyperoxaluria 9.5
2059 breast ductal carcinoma 9.5
2060 lobular neoplasia 9.5
2061 allergic contact dermatitis 9.5
2062 papillary adenocarcinoma 9.5
2063 gallbladder cancer 9.5
2064 chronic granulomatous disease 9.5
2065 carotid artery disease 9.5
2066 turner syndrome 9.5
2067 gestational trophoblastic neoplasm 9.5
2068 choriocarcinoma 9.5
2069 lactic acidosis 9.5
2070 vaginal discharge 9.5
2071 pulmonary fibrosis 9.5
2072 lynch syndrome 9.5
2073 bladder urothelial carcinoma 9.5
2074 trophoblastic neoplasm 9.5
2075 tinea capitis 9.5
2076 mucoepidermoid carcinoma 9.5
2077 benign meningioma 9.5
2078 bile duct cancer 9.5
2079 proliferative glomerulonephritis 9.5
2080 mesangial proliferative glomerulonephritis 9.5
2081 adenocarcinoma in situ 9.5
2082 acute t cell leukemia 9.5
2083 aortic valve insufficiency 9.5
2084 thyroid hyalinizing trabecular adenoma 9.5
2085 follicular adenoma 9.5
2086 adrenal adenoma 9.5
2087 compartment syndrome 9.5
2088 tongue cancer 9.5
2089 fascioliasis 9.5
2090 atrophic gastritis 9.5
2091 evans' syndrome 9.5
2092 cowpox 9.5
2093 pityriasis versicolor 9.5
2094 hard palate cancer 9.5
2095 cholangitis 9.5
2096 lipid storage disease 9.5
2097 dientamoebiasis 9.5
2098 systolic heart failure 9.5
2099 hemorrhoid 9.5
2100 albinism 9.5
2101 hypoalphalipoproteinemia 9.5
2102 morquio syndrome 9.5
2103 primary trimethylaminuria 9.5
2104 47, xxy 9.5
2105 aminoacidopathies 9.5
2106 auditory neuropathy spectrum disorder 9.5
2107 biliary tract cancer 9.5
2108 corticobasal degeneration 9.5
2109 distomatosis 9.5
2110 early-onset, autosomal dominant alzheimer disease 9.5
2111 exercise-induced anaphylaxis 9.5
2112 meningococcal infection 9.5
2113 microscopic polyangiitis 9.5
2114 mthfr gene variant 9.5
2115 mycetoma 9.5
2116 mycobacterium chelonae 9.5
2117 mycobacterium xenopi 9.5
2118 neonatal meningitis 9.5
2119 oral lichen planus 9.5
2120 ring chromosome 3 9.5
2121 slipped capital femoral epiphysis 9.5
2122 stachybotrys chartarum 9.5
2123 triploidy 9.5
2124 febrile seizures 9.5
2125 glycogen storage disease due to glucose-6-phosphatase deficiency 9.5
2126 uniparental disomy of chromosome 15 9.5
2127 cerebral sinovenous thrombosis 9.5
2128 idiopathic nephrotic syndrome 9.5
2129 ethylene glycol poisoning 9.5
2130 disorder of energy metabolism 9.5
2131 fungal keratitis 9.5
2132 maternal uniparental disomy 9.5
2133 paternal uniparental disomy 9.5
2134 glomerular disease 9.5
2135 uremic pruritus 9.5

Comorbidity relations with Multiple Sclerosis via Phenotypic Disease Network (PDN): (showing 5, show less)


Acute Cystitis Decubitus Ulcer
Neurogenic Bladder Paraplegia
Trigeminal Neuralgia

Graphical network of the top 20 diseases related to Multiple Sclerosis:



Diseases related to Multiple Sclerosis

Symptoms & Phenotypes for Multiple Sclerosis

Human phenotypes related to Multiple Sclerosis:

31 (showing 10, show less)
# Description HPO Frequency HPO Source Accession
1 spasticity 31 HP:0001257
2 diplopia 31 HP:0000651
3 emotional lability 31 HP:0000712
4 depressivity 31 HP:0000716
5 muscle weakness 31 HP:0001324
6 paresthesia 31 HP:0003401
7 urinary incontinence 31 HP:0000020
8 incoordination 31 HP:0002311
9 cns demyelination 31 HP:0007305
10 urinary hesitancy 31 HP:0000019

Symptoms via clinical synopsis from OMIM:

56
Neurologic Central Nervous System:
spasticity
emotional lability
depression
high intensity area in white matter on head mri
cognitive dysfunction
more
Genitourinary Bladder:
urinary incontinence
urinary hesitancy
incomplete bladder emptying

Laboratory Abnormalities:
increased csf immunoglobulin levels
oligoclonal bands in csf
myelin basic protein in csf

Head And Neck Eyes:
diplopia
vision loss, monocular

Neurologic Peripheral Nervous System:
incoordination
weakness
sensory loss
paresthesias

Clinical features from OMIM:

126200

UMLS symptoms related to Multiple Sclerosis:


seizures, tremor, back pain, pain, headache, hemiplegia, syncope, chronic pain, sciatica, vertigo/dizziness, sleeplessness, muscle cramp

Drugs & Therapeutics for Multiple Sclerosis

Drugs for Multiple Sclerosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 596, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
acetic acid Approved Phase 4 64-19-7 176
2
Dinoprostone Approved Phase 4 363-24-6 5280360